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Single ablative therapy for PAF has moderate success and many patients present with 
recurrent arrhythmia. We propose that the structure of the RF lesion applied during ablation 
is important in determining recurrences. The nature of the RF lesion was studied using MRI 
with gadolinium  delayed enhanced (DE) imaging  and high signal T2 weighted imaging. 
Levels of DE and T2 were low in pre-procedural scans but rose dramatically immediately 
following the procedure. Acute DE was greater in patients without recurrences compared to 
those with recurrences. Conversely T2 levels were lower in patients without recurrences and 
higher in those with recurrences. On the late scans, T2 reduced to baseline. DE however 
remained and was greater in patients without recurrences. We therefore propose that acute RF 
ablation injury is composed of two types of tissue damage. DE infers largely necrotic tissue 
injury which lasts longer and causes persistent conduction block. T2 is a transitory 
phenomenon co-existing with DE, causing acute conduction block. We propose that 
resolution of oedema is associated with recurrences of PV connection and therefore 
arrhythmia recurrences. Modifications in our ablative techniques to achieve more DE at the 
acute ablation would potentially be important in conferring better ablation outcomes.  
The role of DE imaging was utilised to compare left atrial catheter ablation with robotic 
assisted navigation and standard navigation. A greater circumferential lesion extent by DE 
was observed in the robotic group . This suggests that catheter stability improves tissue 
contact permitting the creation of more contiguous durable scar around the PV antrum. We 
also sought to improve DE imaging sequences to optimise scar visualisation and tested the 






1  Summary 
1.1  Summary of thesis 
1.1.1  Introduction 
Catheter ablation (CA) of paroxysmal atrial fibrillation (AF) is an established treatment 
modality for symptomatic patients with drug refractory paroxysmal AF.  
The principal objective of atrial fibrillation ablation is the electrical disconnection of the 
pulmonary-vein triggers from the atrial substrate pulmonary vein isolation (PVI). 
Whilst acute electrical isolation is almost homogenously  achieved, the long term results 
appear heterogenous  with  between 2-3 repeat ablation procedures being needed to ensure 
freedom from arrhythmia . 
This has subsequently led to a need for an effective tool in assessing catheter ablation lesions 
in patients. Understanding the nature of these radiofrequency lesions (full thickness versus 
partial thickness) assessing their distribution in relation to anatomic landmarks and 
following-up these lesions over time may help improve our knowledge in understanding the 
variation in catheter ablation outcome results and possible underlying mechanisms 
responsible for AF initiation and maintenance. 
The recent advancement in novel cardiac magnetic resonance imaging sequences has allowed 
for the visualisation, quantification and characterisation of post-procedural radiofrequency 
lesions in vivo. Delayed enhancement (DE) imaging performed has been accepted to signify 





-Within the framework of this project, we sought to assess the relationship between DE, T2 
and a combination of DE&T2 to clinical outcome by performing acute and late CMR scans. -
-Next, we examined the importance of catheter stability and contact force in lesion delivery. 
A cardiac MR comparison of radiofrequency ablation lesions created  by using robotic 
navigated systems and catheters with contact force measurement  against lesions created in 
the conventional way using standard catheter was performed.  
-In order to refine delayed enhancement image acquisition, a novel double inversion recovery 
sequence was examined.   
-The application of an automatic lesion segmentation tool that was being developed to 
segment out areas of delayed enhancement on CMR was assessed.  
-Finally, the proof of concept and feasibility of a prototype echo-fluoroscopy view-
synchronized platform was clinically evaluated 
1.1.3  Methodology 
Left atrial lesions created following catheter ablation was assessed on CMR by using delayed 
enhancement and T2 signal. Pre-procedural and both acute (between 18 and 24hours 
following CA) and late post-procedural images (3 months and beyond post CA) were 
acquired. We performed five studies  which are summarised as follows: 
(a) Characterisation of  post ablation lesions into reversible and irreversible atrial tissue 
injury following catheter ablation 
(b) An assessment of the temporal relationship between DE and T2 signal over time 
following catheter ablation and its clinical relevance  
(c) A CMR comparison of lesions created using  robotic navigated systems and catheters 




(d) A comparison of the non-specific dual inversion recovery technique to standard 
inversion recovery by performing both sequenecs in the same patients at pre-
determined time points following contrast administration 
(e) An evaluation of a novel automatic delayed enhancement lesion segmentation tool by 
comparing areas of DE recognized and automatically segmented by the tool to 
manually segmented DE areas by experienced operators 
1.1.4 Results 
We found that acute pulmonary vein isolation was achieved by a combination of reversible 
and irreversible circumferential tissue injury at the PV-LA junction. The greater the ablation 
extent accounted for by reversible injury, the higher is the incidence of AF recurrence. Areas 
of DE over time became more distinct and smaller, whilst T2 signal regressing to almost 
baseline levels. The cardiac MR examination findings in the robotic versus standard ablation 
study suggest that remote robotic assisted navigation systems permit the creation of more 
contiguous, durable scar around the PV antrum.  Higher amount of DE quantified on the late 
scans corresponding to a better clinical outcome was noted in this group. Non-specific dual 
inversion recovery achieved better atrial blood pool suppression conferring improved delayed 
enhancement visualisation alongside facilitating a reduction in scanning time. The automatic 
lesion segmentation tool recognised areas of delayed enhancement and performed appropriate 
segmentation which corresponded to the manual operator segmented areas of DE.  
1.1.5 Conclusion 
Clinical outcome correlates with cardiac MR findings strongly suggest that the creation of 
scar which is contiguous and circumferential results in a better long term outcome. Post 
catheter ablation cardiac MR atrial lesion assessment is a unique invaluable tool that permits 
visualisation, characterisation and quantification of atrial tissue injury. The examination of 




mechanisms promoting mid-long term procedural success. The presence of greater amount of 
delayed enhancement on the late scans suggest a more favourable clinical outcome. The 
overall better results observed in the robotic group is likely a resultant of increased catheter 
stability improving tissue contact and greater catheter control allowing for more accurate 
lesion delivery.  Dual inversion recovery technique allows for better signal to noise ratio 
(SNR) and contrast to noise ratio (CNR) allowing better visualisation of areas of delayed 
enhancement. The appropriate and successful automatic DE segmentation by the novel 
software allows for greater reproducibility in the absence of inter-observer variability. The 
practicability of real-time hybrid X-ray fluoroscopy was demonstrated in both a phantom 
model and a porcine experimental study, followed by a clinical series demonstrating work-
flow feasibility. 
Atrial Fibrillation; Catheter Ablation; Cardiac Magnetic Resonance; Pulmonary Vein 
Isolation; Wide Area Circumferential Ablation, Delayed Enhancement, T2 Signal; Remote 
Robotic Navigation System; Dual Inversion Recovery; Automatic Segmentation; Real-Time 
Hybrid X-Ray Fluoroscopy 
1.2 Keywords 
Atrial Fibrillation; Catheter Ablation; Cardiac Magnetic Resonance; Pulmonary Vein 
Isolation; Wide Area Circumferential Ablation, Delayed Enhancement, T2 Signal; Remote 
Robotic Navigation System; Dual Inversion Recovery; Automatic Segmentation; Real-Time 
Hybrid X-Ray Fluoroscopy 
1.3 Overview of Thesis 
1.3.1  Description of chapters 
Chapter 2 gives an overview of atrial fibrillation including mechanisms for AF, rationale for 




followed by an introduction into magnetic resonance imaging with an overview of the basic 
principles and techniques for CMR. Key concepts for this thesis is introduced, including left 
atrial imaging, delayed enhancement and T2 assessment, robotic navigation system and 
inversion recovery. 
Chapter 3 describes the general methods used for the experimental work in this thesis. 
Chapter 4 reports the acute and late left atrial CMR findings by DE and T2 assessment 
following catheter ablation, the clinical significance of these findings are crystallised by 
correlating the signal evaluation to clinical outcome. 
Chapter 5 reports the CMR study findings comparing lesions created using robotic navigated 
systems and catheters with contact force measurement against lesions created in the 
conventional way. 
Chapter 6 describes the study comparing the non-specific dual inversion recovery technique 
to standard inversion recovery following contrast administration. 
Chapter 7 describes a novel automatic segmentation tool utilized to facilitate lesion 
assessment 
Chapter 8 discusses the relevant findings and explores the clinical utility of fusion imaging 
Chapter 9 describes conclusions from the studies which comprise this thesis 
1.3.2  Contribution of candidate and colleagues 
I designed the clinical studies described within this thesis. I identified and recruited patients 
for the studies. I performed CMR imaging, along with a clinical radiographer, for the patients 
involved in these studies. I assisted in the clinical procedures of AF catheter ablation in both 




O’Neill as first operators for these cases. Cases were also contributed by Drs Michael 
Cooklin and Dr Aldo Rinaldi. I was responsible for data acquisition and data analysis for 
these studies. Drs Bernet Kato and Niloufar Zarinabad  provided statistical advice and help in 
some of the data analysis. For the Dual-Inversion Recovery study, Professor Rene Botnar 
alongside Sarah Peel assisted in developing the sequence and quantifying the SNR and CNR. 
The work on developing an automatic lesion segmentation tool was performed by Dr Rashed 
Karim with lesion quantification being performed by Richard Gere, Dr Rashed Karim and 
myself. The data analysis in this section was performed by both Richard Gere and Dr Rashed 
Karim. The development, phantom and porcine experiments performed in the real-time 
hybrid echo-fluoro study were carried out in conjunction with a team in Phillips comprising a 
team of mathematical and computer experts, and locally by Dr Gang Gao, James Housden 
and Dr Ying Liang Ma.  TOE image acquisition was performed by Dr Ronak Rajani and Dr 






The electrophysiological basis of atrial fibrillation requires both a trigger that initiates the 
dysrhythmia and a substrate that can sustain it. 
1, 2
 The most common triggers of atrial 
fibrillation are ectopic atrial beats that arise from the muscle sleeves of the pulmonary veins. 
3, 4
 These triggers may be provoked by the intrinsic activity of cardiac ganglionic plexi, which 
are clustered in the vicinity of the pulmonary vein–left atrial junction.5, 6 The pulmonary 
vein–left atrial junction and an enlarged atrium harboring fibrosis and inflammation serve as 
the substrate for sustaining wavelets of atrial fibrillation. Episodes of atrial fibrillation lead to 
electrophysiological changes in the atria — namely, shortening of the refractory period of the 
atrial muscle — occurs and predisposes to the development of other triggers and wavelets 
(electrical remodelling). This process results in perpetuation of atrial fibrillation and in a 
greater predisposition to atrial fibrillation. Maintenance of sinus rhythm can reverse these 
changes and mechanisms. Hence, atrial fibrillation begets atrial fibrillation, and sinus rhythm 
begets sinus rhythm. 
7-9
 More persistent atrial fibrillation results in anatomical changes 
including fibrosis and hypertrophy which are more difficult to reverse (anatomical 
remodelling). 
Atrial fibrillation ablation is a therapeutic technique that uses radiofrequency energy 
or freezing to destroy atrial tissue that is involved in the propagation of the dysrhythmia. 
Radiofrequency ablation generates an alternating electrical current that passes through 
myocardial tissue, creating heat energy that conducts to deeper tissue layers. At temperatures 
of 50°C or higher, most tissues undergo irreversible coagulation necrosis resulting in non-
conducting myocardial scar tissue.
10, 11
 Cryoablation destroys tissue by freezing and recently  
laserablation by coagulation necrosis. 
The principal objective of atrial fibrillation ablation is the electrical disconnection of the 





 To achieve this goal, ablation is performed around the pulmonary-vein to obtain electrical 
disconnection between the vein and the atrium. Ablation of sites beyond the pulmonary vein–
left atrial junction in the atrial substrate itself, targeting so-called complex fractionated 
electrograms, is not necessary in paroxysmal atrial fibrillation but may be very important in 
patients with persistent atrial fibrillation.
13
 Although acute electrical isolation of the 
pulmonary veins is achieved in the electrophysiology laboratory, the long term results at 
present time are not as favourable.  Pulmonary vein reconnection is common and between 2-3 




This has subsequently led to a need for an effective tool in assessing catheter ablation 
lesions in patients. Understanding the nature of these radiofrequency lesions (full thickness 
versus partial thickness) assessing their distribution in relation to anatomic landmarks and 
following-up these lesions over time may help improve our knowledge in understanding the 
variation in catheter ablation outcome results and possible underlying mechanisms 
responsible for AF initiation and maintenance. Previously parameters affecting lesion 
creation have been assessed in animal models looking at temperatures achieved, power 
delivered, tissue contact force, catheter orientation, duration of energy delivery and blood 
flow within the cardiac chambers. However, there are technical limitations in extrapolating 
this data directly into patients as catheter orientation, catheter stability, blood flow and exact 
tissue contact force achieved has been difficult to assess. 
The recent advancement 
7,8,9,10
in novel cardiac magnetic resonance imaging sequences 
has allowed for the visualisation, quantification, qualitation  and characterisation of post-
procedural radiofrequency lesions in vivo. This new tool is rapidly proving to be an 
invaluable commodity for researchers, electrophysiologists and patients offering numerous 




magnetic resonance (CMR) imaging is an imaging technique with excellent soft tissue 
contrast and provides high resolution two-dimensional (2D) and three-dimensional (3D) 
images.   
The following paragraphs presents the historical perspective of atrial fibrillation, possible 
mechanisms for atrial fibrillation, rationale for catheter ablation and a summary of the present 
cardiac magnetic resonance studies evaluating the left atrium following catheter ablation. 
2.1 Historical Perspective 
 
Table ‎2-1Chronological overview of events pertaining to the history of Atrial Fibrillation 
Huang Ti Nei,  
Ching Su Wen  
3000BC 
Description of what may 
have been AF in the Yellow 




Animal studies confirming 
fibrillation of the atrium in 
response to ‘ faradic current ’ 
William Harvey  1628 Movement of the right 
atrium was described as 
‘obscure’ and ‘undulating’ 
Arthur Cushny 
1899 
First published case report of 
AF occurring following ovarian 
surgery 
William Withering 
late 1700s Foxglove leaves 
(Digitalispurpurea) use in 
restoring regular pulse 
Fredericq 
1904 
Severance at the level of the 
Bundle of His left the atrium 
fibrillating but the ventricles 
contracting regularly, 
confirming  the atrium as the 
origin for irregular beats 
Robert Adams  
1827 
Irregular pulses in 
association with mitral 
stenosis as first described 








Used recently developed 
graphical techniques for 
analyzing arterial pulses 
Thomas Lewis 
1909 
First  documentation of  atrial 
fibrillation 
electrocardiographically with 
fibrillation waves (f waves) 




Atrial Fibrillation’ was defined in 1909 by Sir Thomas Lewis14 as: 
 ‘when the auricles pass into fibrillation they cease to beat, their walls standing in 




expression of in-coordinate activity’ 
Almost a century later the American College of Cardiology jointly with the 
European Society of Cardiology in 2006 defined atrial fibrillation as
15
: 
‘..a supraventricular tachyarrhythmia characterized by uncoordinated atrial 
activation with consequent deterioration of atrial mechanical function. On the 
electrocardiogram, AF is described by the replacement of consistent P waves by 
rapid oscillations or fibrillatory waves that vary in size, shape, and timing, 
associated with an irregular, frequently rapid ventricular response when 
atrioventricular conduction is intact’ (Figure 2.1) 
 
Figure ‎2-1: Electrocardiogram showing atrial fibrillation (top tracing) with fibrillatory 
waves and sinus rhythm (bottom tracing) with consistent p waves. 
 
Of note, the Chinese chronicles approximately 4000 years ago in the Yellow Emperor’s 
Classic of Internal Medicine (Huang Ti NeiChing Su Wen) 
16
 was the earliest description of 
what may have been atrial fibrillation: 
‘When the pulse is irregular and tremulous and the beats occur at intervals, then 
the impulse of life fades…’ 
 




physicians,  the first description of ‘fibrillation of the auricles’ was made by William Harvey 
in 1628, who described the movement of the right atrium as ‘obscure’ and ‘undulating’. In 
the late 1700s, William Withering described a patient with a ‘weak and irregular pulse’ that 
later became ‘full and more regular’ after treatment with extracts from the foxglove (Digitalis 
purpurea) 
17. With the aid of Laennec’s recently invented stethoscope, Robert Adams 
reported in 1827 the association of irregular pulses with mitral stenosis, with Etienne Marey 
later publishing a pulse tracing from such patient.
16
 Numerous terms were coined for this 
abnormal heart rhythm with Bouilland in1835 describing ‘ataxia of the pulse’, referring to a 
pulse with varying inter-beat intervals and in 1887 Nothnagal using recently developed 
graphical techniques for analyzing arterial pulses, publishing three pulse recordings that he 
termed ‘delirium cordis’: 
‘heartbeats follow each other in complete irregularity…, the height and tension 
of the individual pulse waves are continuously changing’ 
At around the same time, animal studies were being developed in order to evaluate the 
reported clinical observations. In 1874 Velupian described a fibrillating atrium in response to 
application of a strong, continuous (faradic) current who applied the term 
‘frémissementfibrillaire’. Later in 1899 Arthur Cushny, professor of pharmacology at 
University College London published the first case report of atrial fibrillation. His patient was 
3 days following surgery on an ovarian fibroid when she developed a ‘very irregular’ pulse at 
a rate of 120-160 beats per minute. Her pulse was recorded by a ‘Jacques 
sphygmochronograph’, which showed the radial pulse pressure against time. He linked the 
findings of irregularity of the arterial pulse curves, to experimental dogs with induced atrial 
fibrillation. However, doubts existed as to the mechanism of ventricular irregularity 




Fredericq in 1904 found that whilst the atria continued to fibrillate after cutting the bundle of 
His, the ventricles  however began to beat regularly. This confirmed the atria as the source for 
the arrhythmia with irregular impulse propagation to the ventricles through the Bundle of His. 
The main clinical diagnostic breakthrough was the invention of the string galvanometer by 
William Einthoven in 1900. Subsequently, in 1909, a close friend of Einthoven, Sir Thomas 
Lewis at the University College Hospital London, taking advantage of the newly developed 
galvanometer, was the first to document atrial fibrillation electrocardiographically with 





Figure ‎2-2: Electrocardiogram recorded by Thomas Lewis showing sinus rhythm in one patient (upper 
panel) and atrial fibrillation in another patient (lower panel). Fibrillating (f) waves are demonstrated 
 
Subsequently Lewis was able to link this type of electrical activity with fibrillation of the 
atria, which he visually observed in open-chested dogs. 
2.2 Mechanisms of Atrial Fibrillation 
Following these initial observations, there has been a lot of speculation on the precise 




development of several animal models of AF and data from patient studies, we have come to 
appreciate that AF probably has several mechanisms.  
In the 1900s, three theories of AF had evolved (Figure 2.3): 
i) “hyperectopia theory” in which single or multiple rapidly-firing atrial ectopic foci 
lead to fibrillation (Engelmann, Winterberg, Haissaguerre). 
ii) rapid single circuit re-entry (“mother wave”) with fibrillatory conduction (Lewis). 
iii) multiple simultaneous functional re-entry circuits (Mines, Garrey,Allessie). 
 
Figure ‎2-3: Proposed mechanisms of atrial fibrillation, A. Multiple wavelet theory, B.Ectopic 
focus.(Adapted from Garrey, Miles, AllessieEnglemann, Rothberger, Haissaguerre) 
 
2.2.1  Multiple Re-entry circuits 
Re-entry is a disorder of impulse propagation and occurs when an impulse travels around an 
abnormal circuit repetitively based on a central non-conducting area. Re-entry requires an 
appropriately timed stimulus (trigger) that is able enter the circuit, but encounters an area of 
refractory tissue on one side (unidirectional block) and excitable tissue on the other where it 
is able to propagate. When the wavefront reaches the distal end of the circuit there is recovery 
of excitability of the previously refractory tissue, thus allowing the wavefront to pass back up 




In 1906, Mayer had noted that a single stimulus applied to the ring of jellyfish tissue can 
propagate in one direction only and on returning to its origin find that the tissue again is 
excitable and then traverse the circuit over and over again.  
This was the first experiment to demonstrate reentry. Later Mines  used strips of tortoise atria 
and ventricle to form a ring of sufficient size that wavefronts might recirculate.
18
  
In 1914, Garrey et al  published a seminal paper establishing the fundamental concept that a 
critical mass of tissue was necessary to maintain atrial fibrillation. He induced atrial 
fibrillation by introducing faradic current to the tip of one of the atrial appendages. 
When he separated the tip of the atrial appendage using a soft clamp from the rest of the 
atrium the tip of the appendage failed to fibrillate whereas the rest of the atrium did. From 
such observations he concluded that: 
‘any small auricular piece will cease fibrillating even though the excised pieces retained 
their normal properties’. 
This suggested that not all parts of the atria fibrillate as a result of rapidly discharging foci 
but were dependent on stimulation from surrounding areas. Using all the information he 
acquired he proposed that fibrillation was the result of circulating impulses which were either 
halted by areas of conduction block or diverted around these areas to take random paths 
around refractory tissue, termed ‘circus movement’. 
Influenced by the work of Mines  and Mayer, Garrey later proposed that AF was due to:  
‘a series of ring-like circuits of shifting location and multiple complexity’. 
Subsequently Lewis in 1920 [18,19] influenced by the previous work by Mines, Mayer and 
Garrey proposed the following: 
‘In fibrillation a single movement does exist, but the path changes…grossly; but in general 




of many types. We might even assume several circuits, completely or transiently independent 
of each other.’ 
Since the 1960’s, the most popular theory has held that AF consists of multiple wavelets of 
functional re-entry. In 1959, largely based on studies of a vagally mediated model of AF in 
the canine heart, Moe and Abildskov
1, 19-21
 proposed the multiple wavelet theory for AF. 
They suggested that during AF, multiple wavelets wander through the atrial myocardium 
without re-entry to the site of origin. The pathways of these wavelets were not anatomically 
determined but rather were determined by local atrial refractoriness and excitability, in other 
words areas of functional conduction block. Because of this, the wavelets could collide and 
annihilate, divide, or fluctuate in size and velocity. Using a computer model they noted the 




Just over 25 years ago in 1985, Allessie and coworkers
22
 tested the multiple wavelet 
hypothesis by mapping the spread of excitation of induced AF in isolated blood-perfused 
canine atria. Here, they confirmed the presence of multiple wandering wavelets, which 
exhibited various properties such as fluctuations in size and changes in direction and 





Figure ‎2-4: Multiple re-entry wavelets during sustained atrial fibrillation in Lagendorffperfusedcanine 





2.2.2  Multiple ectopic foci 
Despite the above theories, some groups suggested that AF was due to rapidly firing atrial 
foci. Engelmann
24
 first reported that individual heart fibres can generate significant 
spontaneous rhythmicity. In 1907, Winterberg
25
 further developed the theory that multiple 
ectopic foci produce the uncoordinated atrial activity associated with AF. In 1915 Rothberger 
and Winterberg suggested that a single rapidly firing focus at 3000 beats per minute underlies 
AF 
26
. Support for this concept came from work of Scherf et al in the 1950’s 27-29. They 
placed aconitine, a plant alkaloid, on the atria and demonstrated that a rapid and irregular 
atrial rhythm could be generated. When the site of the aconitine application was excluded by 
cooling, the tachycardia terminated. 
Subsequent studies in the 1970’s by Gotoetal30and Azuma et al  31 found that aconitine 
placed on rabbit atria indeed caused abnormal automaticity with induction of AF. These 
studies were not widely accepted, however recently it is now appreciated that an atrial 
“focus” firing rapidly not only initiates but also is capable of sustaining AF and may be the 
mechanism in some patients with paroxysmal AF. Haissaguerre
12
et al  reported this 




foci appeared around the pulmonary veins (n=65), in particular the main trunk of the left 
upper pulmonary vein (n=31) (Figure 2.5). 
 
 
Figure ‎2-5: Sites of atrial foci thought to be responsible for triggering atrial fibrillation 




Haissaguerre postulated that AF occurred as a result of a single focal discharge or a short 
burst of two or more repetitive focal discharges. He also demonstrated that application of 
radiofrequency energy in 38 patients successfully abolished these foci and their paroxysms of 
AF supporting the theory that these foci were triggering AF. It was later determined that in 
patients with frequent paroxysms of AF, the muscular sleeve of the pulmonary veins displays 
electrophysiological properties distinct from those of both the adjacent left atrial muscle and 
the muscular sleeve of the pulmonary veins in control subjects without AF
32
. Although atrial 
tissue and the muscular sleeves of other cardiac veins, including the coronary sinus 
33
, the 
vein of Marshall 
34
 and the superior vena cava 
35, 36
, have been implicated as triggers for AF, 




These foci have gained a lot of attention as potential ‘curative’ targets for patients with 
paroxysmal AF and forms the basis of the present clinical ablative strategy widely employed. 
It is important to note that the demonstration of focal tachyarrhythmias in patients with 
paroxysmal AF has challenged the multiple wavelet hypothesis. The relative contribution of 
these 2 competing mechanisms in explaining AF in patients with and without structural heart 
disease remains largely unknown. These theories are not mutually exclusive and a possible 
scenario is that ectopic foci can provide the trigger for initiating re-entry within the atria, or if 
it is rapid and sustained, may maintain AF for short periods. The trigger by a single focal 
source can be explained by the concept of ‘fibrillatory conduction’ whereby a single impulse 
might divide and reenter either functionally or around anatomical boundaries 
37
. However 
after a critical period, physiological and anatomical changes develop in the atria such that AF 
persists despite the disappearance of the precipitating driver or drivers 
38
, in which case AF 
becomes persistent and self-perpetuates. 
2.3 Self Perpetuation of Atrial Fibrillation 
2.3.1 2.3.1 Background 
In 1987, Kopecky
39
showed that between 18%-24% of patients having paroxysmal AF went 
on to develop persistent AF in the absence of progressive underlying heart disease. This 
suggested that the arrhythmia itself causes changes that result in its own self-perpetuation. An 
animal study published as an abstract in 1985 indicated that when AF was maintained by 
electrical stimulation for several weeks in dogs, it often sustained itself when electrical 
stimulation was discontinued 
40
. Further work  was carried out in 1994 by Wijfells et al . Here  
a goat model of AF was created with the implantation of epicardial electrodes which 




rhythm was detected; and conversely burst pacing was inhibited when atrial fibrillation was 




Figure ‎2-6:The functioning of the automatic fibrillation pacemaker (Adapted from Wijffels et.al.9). 
 
At the start of the protocol the induced AF episodes were short (lasting a few seconds) after 
which a new episode was induced automatically. With an increased duration of the 
stimulation protocol, the induced AF episodes prolonged until AF did not convert 
spontaneously, in other words becoming persistent AF (see Figure 2.7). This landmark paper 
titled ‘Atrial Fibrillation begets atrial fibrillation’ was the first published study to 







Figure ‎2-7: Prolongation of the duration of episodes of electrically induced atrial 




In the same year Morillo et al 
7
showed that 6 weeks of rapid atrial pacing (400bpm) in dogs 
strongly promoted the ability to maintain AF, with changes similar to those observed by 
Wijfells et al 
9
. 
2.3.2 Underlying mechanism for the self-perpetuation of AF 
As described earlier, in the 1960s Moe and coworkers introduced the multiple wavelet 
hypothesis of functional re-entry and postulated that the self-perpetuation of AF could be 
explained by this theory based on the average number of wavelets present in the atria
20, 21
. If 
the number of wavelets is high then the probability that all the wavelets will extinguish 
simultaneously is low, therefore AF would self-perpetuate. The critical number of wavelets 
needed to stabilize AF was estimated to be between four and six
22
. Figure 2.8 shows an 
example of  high density maps from the right atrial free wall during a short episode of AF and 




During acute AF the right atrium was activated by a single wave (type I AF) and therefore 
terminated quickly, whereas after more prolonged AF the atrium was activated by numerous 





Figure ‎2-8: High density mapping of the right atrial free wall in a goat during acutely induced (top) and 





It was recognized that the number of wavelets that can coexist in the atria is dependant on the 
wavelength of the atrial impulse (distance traveled by the electrical impulse) and the total 
surface area of the atria
42-44
. The importance of the wavelength for re-entry was first 
discussed by Lewis in 1925 
14
 and later defined by Wiener and Rosenbleuth
45
 in 1946 as the 






experiments in dogs to determine the effect of wavelength on inducibility of arrhythmias. 
They verified that premature impulses associated with small wavelengths were more likely to 
induce AF whereas longer wavelengths induced repetitive responses only. In addition 
interventions which decrease the wavelength (such as vagal stimulation) reduces the circuit 
size and permits more reentry circuits to coexist, making simultaneous spontaneous 
termination of all circuits unlikely and promoting AF, whereas interventions that increase 
wavelength reduce the number of circuits and suppress AF
44, 46
. This has important clinical 
relevance as drugs that increase the wavelength are more likely to terminate AF.  





. Support for this came from pharmacological 
experiments by Wang et al in which termination of AF by class IC antiarrhythmic drugs was 
preceded by a decrease in the mean number of wavelets
44, 47
. 
2.4 Rationale for Catheter Ablation in Atrial Fibrillation 
Although the mechanistic understanding of fibrillatory process remains to be confirmed, the 
development of recent controlled studies indicate a greater effect of catheter ablation on 
episodes of atrial fibrillation in comparison to AAD’s for paroxysmal atrial fibrillation (A4 
study and Thermocool). The lack of anti-arrhythmic drug (AAD) efficacy and the 
development of catheter-based technologies over the last decade have fuelled catheter AF 
ablation from an investigational technique to an effective alternative to AAD. The impressive 
improvement in the results of catheter ablation in all forms of AF compared with AAD over 
the last decade indicates that this approach can be considered early in the management of 
patients with AF, regardless of their baseline left ventricular function. 




2.4.1  Multiple Wavelet Hypothesis 
 The multiple wavelet hypothesis as discussed above by Moe,
19
 with supportive/contributory 
experimental work by Allessie,
22
 was the predominant hypothesis prior to the late 1990s, and 
formed the basis on which Cox's Maze procedure was developed. The developments of 
surgical ablation of AF culminated in the Maze III
49
, which incorporates four lesion sets: (i) 
encirclement of the pulmonary veins; (ii) a lesion joining the circumferential PV lesion to the 
mitral annulus with amputation of the left atrial appendage; (iii) a circumferential lesion in 
the coronary sinus; (iv) ablation of the right atrium. Although catheter ablation approaches 
based on the early surgical approaches were tried by a number of groups, the success rate was 
disappointing, with an unacceptable high complication rate.
50
 
2.4.2  Focal Source Hypothesis 
The observation that AF could be triggered from ectopics originating from the pulmonary 
veins,
12
 with ablation at the source of the ectopy eliminating AF, changed the emphasis of 
catheter ablation away from linear lesions compartmentalizing the atria to treating focal 
sources. Although focal sources, incorporating automaticity and/or local re-entry, have been 
implicated in both atria,
51-53
 the majority reside within the left atrium, which is consistent 
with a dominant role for the left atrium in human AF.  
2.4.3  Catheter Ablation 
Catheter ablation of AF is now a realistic therapeutic option across a broad spectrum of 
patients -from patients with paroxysmal AF to those with long-lasting persistent AF
54
, 
including patients with moderate-to-severe left ventricular impairment.
13, 55
 There is evidence 
to suggest that restoration and maintenance of sinus rhythm by catheter ablation may lead to 
improved outcomes in these patients.
55, 56
 
Most centres, accept patients for catheter ablation if they have symptomatic paroxysmal AF 




fibrillation are considered for ablation if they are symptomatic and have failed treatment with 
more than one conventional antiarrhythmic drug, electrical cardioversion, or both. In nearly 
half of patients with long-lasting persistent AF, a second procedure is necessary to maintain 
sinus rhythm, and there are no absolute exclusion criteria nor is there a predetermined limit to 
the number of procedures performed per patient. With the growing body of evidence to 
support a safe and effective role for catheter ablation in patients with both atrial fibrillation 
and heart failure,
55, 56
ablation is offered to patients with atrial fibrillation, echocardiographic 
evidence of left ventricular dysfunction, New York Heart Association heart failure symptoms 
of grade II or more, and the absence of an alternative explanation for their cardiac 
dysfunction. 
2.4.3.1 Paroxysmal Atrial Fibrillation 
Pulmonary vein isolation, whether ostial or antral, is the cornerstone in treatment for 
paroxysmal AF. Electrical isolation of all pulmonary veins is the endpoint of ablation, and 
this objective measure of pulmonary vein disconnection is easy to confirm and results in 
maintenance of sinus rhythm in between 60% and 85% of patients.
57, 58
 The difficulty is how 
to improve on this. Although most of the clinical recurrences associated with this procedure 
are due to lesion recovery, this does not account for all recurrences.
59-61
 
The role of additional substrate modification in paroxysmal AF is controversial. Strategies 
based on targeting of complex fractionated atrial electrograms (CFAE) result in maintenance 
of sinus rhythm in a mixed population of patients with both paroxysmal and long-lasting 
persistent AF in 76% of patients with a single procedure, without necessarily achieving 
pulmonary vein isolation. A majority of lesions in patients with paroxysmal AF, however, 
were located around the pulmonary veins. The addition of linear lesions (a roof line 




mitral annulus to the inferior pulmonary vein) to pulmonary vein isolation improves success 
rates from 69% to 91% at 18-month follow-up.
62, 63
 
The question that is not yet fully answered is how to determine which patients require 
substrate modification in addition to pulmonary vein isolation during the index procedure. 
Non-inducibility of AF can be used as an endpoint in paroxysmal AF and the subsequent 
need for substrate modification, yet this may lead to an overtreatment, that is, excessive 
ablation, in some patients
64-66
. An alternative option is to perform substrate modification 
during a second procedure in patients with recurrent AF despite proven pulmonary vein 
isolation. 
2.4.3.2 Long-Lasting Persistent Atrial Fibrillation 
The mechanisms underlying long-lasting persistent AF are more complex and multifactorial. 
Numerous early studies of pulmonary vein isolation (PVI) included patients with both 
paroxysmal and long-lasting persistent AF, universally demonstrating a much lower freedom 
of recurrent AF in patients with long-lasting persistent AF. With circumferential pulmonary 
vein ablation using an electroanatomic mapping technique, freedom from AF was reported in 
85% of patients with paroxysmal AF and 68% of those with chronic AF.
67
 A further study, 
also using a circumferential mapping catheter-guided approach, reported an even lower 
freedom from recurrent AF in persistent (22%) versus paroxysmal (70%) AF, despite 
achieving electrical isolation in 94% of targeted veins.
68
 Using a basket catheter to achieve a 
100% rate of PV isolation, freedom from AF was demonstrated in 70% of patients with 
paroxysmal but in only 44% of patients with persistent AF,
69
 further confirming that 
extension of the technique of PVI alone from patients with paroxysmal to long-lasting 
persistent AF was inadequate. 
The addition of left atrial substrate modification using electrogram-based or linear ablation 
considerably improves the outcomes in patients with long-lasting persistent AF.
70




randomized study, the addition of left atrial linear lesions (left atrial roof line and a mitral 
isthmus line) improved the outcome in patients at 16-month follow-up from 20% with PVI 
alone to 69% with PVI and substrate modification. This was despite evidence of bidirectional 
block in only 44% of patients with a roof line and 72% with a mitral isthmus line.
70
 The 
incremental benefit of substrate modification (PVI and left atrial linear lesions with 
bidirectional block) was also seen in a population of patients with heart failure, with 69% of 
patients being in sinus rhythm, off all antiarrhythmic medication at 1 year.
55
 
In the above approaches, the endpoint is a technical endpoint, that is, completion of PVI or 
linear block; but the procedure is terminated by DC or pharmacological cardioversion in 55% 
to 90% of cases. In contrast to paroxysmal AF, where noninducibility of AF can be achieved 
in most patients,
63, 71
the same is not true in long-lasting persistent AF as AF/AT is 
consistently inducible in the large majority of patients at the end of the index procedure.  
2.5 Targets of Catheter Ablation  
The therapeutic mechanisms of action and target substrates of catheter ablation for atrial 
fibrillation are now thought to be more complex than previously recognized.  Whilst catheter 
ablation for atrial fibrillation was initially focused on pulmonary vein isolation, more recently 
the net has widened substantially to include further supplementary approaches.  Four 
different approaches to catheter ablation of atrial fibrillation are described below: 
 1 Isolation of the triggers and perpetuating reentrant circuits residing in the pulmonary 
veins (pioneered by Jais and Haissaguerre). 
 2 Disruption of the substrate for perpetuating rotors in the antra of the pulmonary 
veins and the posterior left atrium (pioneered by Pappone). 
 3 Targeted ablation of ganglionated autonomic plexi in the epicardial fat pads 




 4 Disruption of putative dominant rotors in the left and right atria proper as 
recognized by high-frequency complex fractionated electrograms during mapping of 
atrial fibrillation (pioneered by Nadamanee). 
 5  Mapping of rotors using multipolar catheters ( pioneered by Narayan) 
Procedural targets of catheter ablation for AF include PV electrical disconnection and 
additional lesion lines (mitral and roof lines, the endocardial/pericardial coronary sinus [CS] 
disconnection). The sequence of multiple targets essentially depends on the clinical form of 
AF (paroxysmal, persistent or permanent AF) and the patient’s clinical characteristics. 
2.5.1  Pulmonary Vein Disconnection  
PV isolation is the primary step in all AF patients undergoing catheter ablation, and is 
performed by eliminating PV potentials as guided by the Lasso catheter or by encircling 
atrium he point by point (wide area circumferential ablation). PV disconnection is obtained 
by optimal catheter stability and tissue contact, which results in attenuation of atrial 
electrograms during each radiofrequency (RF) energy application. Partially ablated signals 
require further RF applications before moving on to the next ablation site. 
2.5.2 Autonomic Targets with Vagal Denervation 
Where possible, elimination of vagal reflexes at innervation sites during the procedure 
represents one of the most important targets, since vagal denervation is a strong predictor for 
long-term
77
. Haissaguerre’s group were the first to demonstrate that CPVA induces a long-
term but transient vagal denervation that enhances the efficacy of the procedure in terms of 
longterm outcome.
72
 These results have been confirmed by many other authors using various 
AF ablation approaches, and vagal denervation now constitutes a fascinating new AF ablation 
strategy. Haissaguerre’s results on the modification of heart-rate variability (HRV) 




While performing the standard CPVA lesion set, RF applications evoke vagal reflexes in up 
to 30% of patients. Vagal reflexes are considered to include sinus bradycardia (<40 beats per 
minute), asystole, AV block and hypotension that occurs within a few seconds after the onset 
of RF application. If a reflex is elicited, RF energy is delivered until such reflexes are 
abolished, or for up to 30 seconds. The end-point of ablation at these sites is termination of 
the reflex, followed by sinus tachycardia or AF. Failure to reproduce the reflexes with 
repeated RF applications is considered as confirmation of denervation. Complete local vagal 
denervation is defined by the abolition of all vagal reflexes. Haissaguerre’s group reported a 
detailed ‘autonomic map’ of the left atrium as a target for ablation, showing that, like the left 
superior PV, the septal region is richly innervated.
72
 
2.5.3  Linear Lesions  
Additional ablation lines alter the AF substrate by eliminating large macro-re-entrant circuits 
able to sustain AF and/or AT.
10–16
 Standard CPVA linear lesions include the mitral isthmus 
line, the roof line and the posterior wall line.
11–16
 Multiple additional linear lesions in the left 
atrium or right atrium (bi-atrial lesions) are required in patients with permanent AF to obtain 
stable sinus rhythm or AF/AT non-inducibility at the end of the index procedure (CPVA 
stepwise approach). Each ablation target is performed sequentially based on the cumulative 
increase of AF cycle length until conversion to sinus rhythm or an AT, which is then mapped 
conventionally and ablated.
73 
In our experience, completeness of lesion lines is important, but 
in many cases achievement of complete block is unnecessary – particularly in the mitral 
isthmus line, where a delay of about 100ms is sufficient to prevent post-ablation macro-re-
entrant left AT.
74
 If necessary, adjunctive linear ablation (usually the septum or the base of 




2.5.4 Coronary Sinus Disconnection  
If AF/AT inducibility persists even after cardioversion, we accurately revisit lesion lines and 
encircled areas to check for residual potentials, and apply RF where needed. Conduction 
block is assessed by the presence of a corridor of double potentials and demonstration of 
activation moving towards the line of block on both sides. Rapid atrial activity from the 
musculature of the CS may be a driver for long-lasting or permanent AF. Electrical 
disconnection of the coronary sinus from the atrium is performed by endocardial or epicardial 
ablation, or both. Total elimination of CS activity is the ideal end-point, but organisation of 
CS activity and/or slowing of local rate with dissociation between CS and left atrium 
potential activity is also considered proof of CS isolation. Endocardial and/or epicardial CS 
sites are frequent ablation targets in patients with permanent AF and enlarged atria. 
2.5.5 Post-ablation Artrial Fibrillation 
If targets are successfully achieved in the index procedure, post-ablation ATs may occur in  
patients, and usually are macro- or microre- entrant gap-related rather than focal 
tachycardias.
75
 Here,PVreconduction is the main cause of AT.
76
 In addressing this with a 
further procedure, PV isolation should be systematically checked as the first step in the AT 
mapping process. The next step is to exclude macroreentry around the mitral annulus or 
utilizing the roof by sequential mapping around the mitral annulus for the former and the 
anterior and posterior walls for the latter, with confirmation with entrainment maneuvers. If 
macroreentry as a mechanism is eliminated, the next step is to map the atria to find a region 
with centrifugal activation. Whilst these tachycardias have been previously thought to be 
“focal,” Haissaguirre’s group have found that a majority of so-called focal ATs are actually 





Figure ‎2-9: Mapping focal sources during atrial tachycardia-differing perspectives dependent upon the 
mapping system.Upper panel. Using the multipolepentaray catheter, discrete electrograms with a 
consistent activation sequence are seen. When the catheter is placed near the left superior pulmonary 
vein, activation in all spines appears on time, with the reference catheter in the coronary sinus, on the 
bottom of the trace. As the catheter is moved progressively toward the source, activation becomes 
progressively earlier in spine D, indicating the direction of activation. In the septum there is a dramatic 
change of mapping through the pentaray catheter, switching from relatively synchronous activation to 
complex activation, spanning all the cycle length when the catheter is placed directly above the small 
localized‎source.‎This‎source‎is‎likely‎due‎to‎small‎localized‎reentry,‎as‎conﬁrmed‎by‎entrainment‎
mapping. In the lower panel, the electroanatomical map from this patient gives a different perspective. 
The earliest activation can be seen to come from the inferior septum; but, in fact, considerable 
postprocessing‎was‎necessary‎to‎achieve‎a‎map,‎such‎as‎the‎one‎demonstrated,‎as‎it‎is‎difﬁcult‎to‎assign‎
temporal information to the signals seen in the upper panel, when the mapping catheter is directly above 
the source. The multiple electrograms at the source have been assigned a single, earliest, timepoint. 
Ablation at the source location restored sinus rhythm within 10 seconds (righthand panel). This example 
demonstrates that without a global perspective, given by the multipole catheter, point by point activation 







Figure ‎2-10: Localized temporal gradient. In this example, a source is located in the inferior left atrium. 
As the mapping catheter is brought to the periphery there is an activation gradient between the two 
bipoles; as the mapping catheter is placed across the source, the gradient becomes more pronounced, 
suggesting that the catheter is across two parts of a small localized circuit, or rotor, that may be capable 




2.6 Technical Improvement  
2.6.1  Remote Robotic Navigation Systems 
Currently, most catheter ablation procedures in patients with AF are performed with manual 
catheters, which requires advanced operator skills and experience with catheter manipulation 
and ablation. The feasibility of the remote system, which is not operator-dependent, may 
represent an attractive alternative approach in many laboratories worldwide to reproduce the 
success rates of the pioneering groups while minimising risks. Currently, two main systems 
for magnetic and robotic navigation are available for clinical use (Stereotaxis and Hansen 
systems, respectively). The safety profile for both systems have been examined and FDA 




entering the third year. Clinical efficacy results to-date have been largely based on single 
centre studies and further larger multi-centre studies are needed to establish this tools clinical 
utility and justify the additional costs incurred in purchasing the systems. 
2.6.2 Balloon Technology 
Balloon technology for PV isolation is not frequently used, as in most patients with AF 
catheter ablation is not limited to PV disconnection alone, and the achievement of additional 
multiple targets requires a combination of standard catheter ablation alongside this 
technology. One advantage of the balloon shaped catheter is the shorter time needed in 
energy delivery to the PV-LA junction. Neverthless, PVs have largely variable anatomies 
from patient to patient, with a wide range of diameters, and the frequent presence of common 
ostia in up to 30% of patients makes the use of balloon-based catheters challenging. 
2.6.3  Newer Energy Sources 
The safety and efficacy of cryo energy and more recently laser energy appear promising and 
require large multi-centre studies to ascertain both safety and long term efficacy.  
2.6.4  Force Sensing Catheter 
Adequate tissue contact is integral in creating durable ablation lesions. Catheters with force 
sensing features allows the operator to ascertain catheter-tissue contact and titrate the delivery 
of force applied accordingly in order to create full thickness transmural lesions. Preliminary 
results on the safety of this catheter has appeared to be promising in the Toccata study and 
further multi-centre studies are on the way to assess mid-long term efficacy.  
2.7 Variations in reported post-ablation clinical outcome 
Differences in success rates for similar procedural techniques for catheter ablation of atrial 




 1   Duration and location of clinical and electrocardiographic follow-up (on-site vs 
remote third party). 
 2   Inclusion of long periods of cardiac monitoring to detect asymptomatic recurrences 
of paroxysmal atrial fibrillation (pioneered by Kottkamp and Hindricks). The prevalence of 
asymptomatic recurrences of atrial fibrillation postablation may have been previously 
underestimated. Reduction of symptomatic episodes post-ablation may arise from a placebo 
effect or autonomic denervation, and exclusive reliance on patient reporting of symptomatic 
recurrences as the sole endpoint for determination of efficacy may contribute significantly to 
the variation in clinical outcome reported by different centres. 
 3  Inclusion or exclusion of early recurrences of atrial fibrillation as procedural 
failures (blanking period). It is recognized that a transient increase in atrial arrhythmias may 
be seen in the early post-procedural period (presumably due to subclinical pericarditis after 
catheter ablation), and over time, a significant proportion of such patients subsequently 
become free of atrial fibrillation. 
 4   Use of Kaplan-Meier curves of freedom from atrial fibrillation recurrence as 
opposed to incidence of occurrence during predetermined serial time windows on follow-up 
(e.g., 3, 6, and 12 months postprocedure—use of a Kaplan-Meier curve and time to first 
recurrence results in a lower success rate being reported). Time to first recurrence has the 
advantage of being relatively simple to apply and easy to compare with outcome of 
antiarrhythmic drug therapy but is clinically less meaningful. 
 
Consideration may need to be given to the adoption of a subclassification of atrial fibrillation 
based on clinical criteria if the magnitude of therapeutic impact of catheter ablation on 
patients' quality of life is to be meaningfully assessed. For a patient who is transformed from 




spontaneous terminations preablation to a pattern of asymptomatic or symptomatic short-
lived episodes of transient atrial fibrillation (lasting 30 seconds or 1 minute) postablation, the 
procedure could be deemed clinically successful. In contrast, a binary outcome analysis 
limited to whether a patient has any recurrence of atrial fibrillation at any time or is free of 
atrial fibrillation recurrence would classify the ablation as a failed procedure and any clinical 
benefit to the patient would not be recognized. These endpoints extend to pharmacologic 
therapy. 
Beyond differences in follow-up and outcome analysis, variations in procedural techniques 
undoubtedly contribute to the wide range of outcomes reported from different centers. The 
vast majority of investigators continue to employ radiofrequency energy as the primary 
ablation modality. However, there are substantial differences in procedural technique 
including the variation in electrodes size (4 mm, 8 mm, and irrigated), duration of 
radiofrequency applications (5–60 seconds), power settings (30–70 W), temperature limits 
(40°C–43°C for irrigated and 50°C–70°C for nonirrigated) currently used at different 
laboratories. In some centers, different settings are now used in different atrial locations with 
lower settings used for the posterior left atrial wall because of the risk of esophageal fistula 
formation. In vitro and in vivo studies have shown that differences of >40°C can develop 
between electrode tip temperatures at the endocardial interface and intramyocardial 
temperatures and, thus, steam pops can occur without prior achievement of a high electrode 
temperatures (Bunch and Packer). This temperature difference is greater for 8 mm electrodes 
than for 4 mm electrodes. More thrombus formation is seen with 8 mm electrodes compared 





2.8 Magnetic resonance imaging 
2.8.1 Brief Historical Perspective of MR Imaging 
The phenomenon of nuclear magnetic resonance was described in the 1940’s independently 
by both Felix Bloch and Edward Purcell.  This was used widely over the subsequent two 
decades for analysing chemical compounds. It was only in the 1970’s following MR tissue 
characterisation by Damadian when MRI application entered the clinical arena. It’s imaging 
application began with Lauterbur having the idea of applying magnetic field gradients in 
three dimensions to derive spatial orientation using MRI. Subsequent introduction of phase 
and frequency encoding introduced by Ernst alongside the Fourier transformation forms the 
basis of modern MRI techniques. This was taken a step further with Mansfield developing 
echo-planar imaging, with improvements in the use of gradients and signal analysis.  
2.8.2  Basic Principles of CMR 
The hydrogen atom consists of a positively charged proton and is abundant in the human 
body. This forms the basis for the use of MRI in medical imaging. The proton has an inherent 
spin, which creates a tiny magnetic field. In the tissues of the body, the magnetic fields 
resulting from each proton are randomly distributed. When the body is placed in a large and 
powerful magnet, these tiny magnetic fields align with the large external magnetic field and 
reach equilibrium. This equilibrium can be disturbed  by applying energy to the to the body’s 
tissues (“excitation”). The latter is achieved by using a radiofrequency (RF) pulse, provided 
the pulse is of the same resonance frequency as that of the protons. The result of the 
excitation with the RF pulse is a rotational movement of the total magnetization, called 
precession. (The frequency of precessioin for protons is proportional to the magnetic field 
strength and the strength of the magnetization is dependent on the proton density in the 
tissue.) The angle of magnetization is moved to an angle away from the main magnetic field 




the main axis of the magnetic field, resulting in high frequency alternating magnetic field. 
This gives rise to a signal, which is a voltage that can be measured in a receiver coil.  
However the signal is only transient, as the nuclei gives off the acquired energy back to the 
surrounding tissues and the magnetization realigns in the longitudinal plane with the main 
magnetic field, at an exponential rate. This is termed longitudinal relaxation. The rate at 
which this happens depends on the characteristics of the tissue – if the equilibrium is restored 
more quickly, the tissue has a short T1 (longitudinal) relaxation time. The second aspect of 
restoring equilibrium is loss of the transverse component of magnetisizationie that which is in 
the plane perpendicular to the axis of the magnetic field. This happens because of the 
interaction between different protons causing inhomogeneities in the magnetic field. The 
rotating vector of magnetisization are fanned out in (“dephased”) such that they are all not 
pointing in the same direction. Although they remain within the plane perpendicular to the 
magnetic field. As a result, the sum of these rotating vectors is reduced and so is the signal. 
This is known as a transverse relaxation. Again, the speed at which this occurs is dependent 
on tissue properties which govern the T2 (transverse) relaxation time. 
 Special orientation is necessary in order to create an image. This is made possible 
using gradient fields. In contrast to the static field of the magnet, gradient fields can be 
altered over time in all 3 dimensions. In this way, a 2D slice can be selected by applying a 
gradient in the direction perpendicular to it, whilst the excitation RF pulse is transmitted. The 
pulse will only have an effect on the slice of tissue in which the protons have the same 
resonance frequency as the pulse itself. The signal in-doctored in the detector coil is 
described by sine function. The frequency of this function are used to define spatial 
orientation. Phase differences result from the use of a gradient field in one direction (“phase 
encoding”) and frequency differences in the signal result from a gradient field applied in the 




multiple times (this is the number of phase encoding steps) in order to acquire all of the 
spatial frequency components needed to make the image. The time between consecutive 
measurements is called the repetition time (“TR”). The image can then be calculated using 
these individual spatial frequency components using Fourier transformation. This gives a 
representation of the signals in the frequency domain. The digitized representations of these 
signals are converted into a data matrix called k-space which is derived on one axis from 
frequency encoding information and on the other from phase encoding information. Data in 
the centre of k-space encodes contrast information – as it has low spatial frequency but high 
amplitude – whereas data in the periphery of k-space provides image sharpness, as it has high 
spatial frequency but low amplitude. 
2.8.3  Techniques for CMR 
2.8.3.1  Spin Echo 
This sequence uses a 180 degree pulse at a given time after the excitation RF pulse, in order 
to reverse the dephasing of the transverse magnetisization. This magnetisization vectors come 
back into phase and produce a spin-echo. The echo time (“TE”) is the time between the initial 
RF pulse (a 90 degree pulse) and the maximum spin echo signal, so the 180 degree pulse is 





Figure ‎2-11: The spin echo sequence. A) - The vertical red arrow is the average magnetic moment of a 
group of spins, such as protons. All are vertical in the vertical magnetic field and spinning on their long 
axis, but this illustration is in a rotating reference frame where the spins are stationary on average. B) A 
90 degree pulse has been applied that flips the arrow into the horizontal (x-y) plane. C) Due to local 
magnetic field in-homogeneities (variations in the magnetic field at different parts of the sample that are 
constant in time), as the net moment processes, some spins slow down due to lower local field strength 
(and so begin to progressively trail behind) while some speed up due to higher field strength and start 
getting ahead of the others. This makes the signal decay. D) A 180 degree pulse is now applied so that the 
slower spins lead ahead of the main moment and the fast ones trail behind. E) Progressively, the fast 
moments catch up with the main moment and the slow moments drift back toward the main moment. F) 
Complete refocusing has occurred and at this time, an accurate T2 echo can be measured with 
all T2 * effects removed. Quite separately, return of the red arrow towards the vertical (not shown) would 
reflect the T1 relaxation. 
 
 Spin echo sequences are primarily used to define anatomy in a two dimensional 
image. This is very little signal from the blood pool, so these are often called black-blood 
images. This sequences are often used to visualize cardiovascular in detail. ECG and 
respiratory gating are needed to avoid motion artefact. Image acquisition in the past was 
relatively slow but has been improved with fast spin echo sequences to allow acquisition 
within a single breath-hold. A great strength of spin echo imaging is in the tissue 
characterisation. Depending on the weighting to T1 or T2 different tissue properties can be 




2.8.3.2  Gradient Echo  
Gradient echo sequences allow much shorter acquisition times than spin echo sequences. This 
is because of the angle of the excitation pulse is smaller (less than 90 degrees) so the time 
needed for longitudinal relaxation is shorter. Therefore repetition times can be used. This 
permits imaging of multiple phases throughout the cardiac cycle, and is used to provide cine 
images using ECG gating. The typical gradient echo sequence is a steady-state free precision 
(SSFP), which is well suited to assess cardiac function as there is a good contrast between 
blood and myocardium. A steady state free precision imaging allows visualization of cardiac 
function in conventional views, as would be used in 2-D echocardiography. The advantages 
of this approach over echocardiography include special resolution, lack of dependence of 
acoustic windows and freedom from operator variability. 
 
Figure ‎2-12: The gradient echo sequences show a wide range of variations compared to the spin echo and 
inversion recovery sequences. Not only is the basic sequence varied by adding dephasing or rephasing 
gradients at the end of the sequence, but there is a significant extra variable to specify in addition to 
things like the TR and TE. This variable is the flip or tip angle of the spins. The flip angle is usually at or 
close to 90 degrees for a spin echo sequence but commonly varies over a range of about 10 to 80 degrees 
with gradient echo sequences. 
 
 Global right and left ventricular function can be quantified using a series of parallel 
breath-hold images (a stack) either in short axis or axial plane. Regional LV function is 




SSFP images provide a high signal to noise ratio and may also be used for the 3 dimensional 
imaging of the heart to give angiographic images without the need for a contrast agent. 
2.8.3.3  Parallel Imaging 
In order to eliminate the effect of respiratory motion, breath-hold images are often used in 
CMR. Parallel imaging is one technique to reduce the acquisition time so that the duration of 
the breath-hold can be minimised. An approach that is commonly used is sensitivity encoding 
(SENSE). There are several RF surface coils (or phase array coils), which receive the signal, 
and are at different positions. The sensitivity of each coil reduces with the distance of the coil 
from alternating magnetic field which is generating the signal. Therefore the coils have 
different sensitivity maps. The sensitivity maps of different coils can be used to reconstruct 
the image from a smaller field of view by separating out signal from within this area, from 
signal which is folded-over from outside this area. This allows the time taken to perform the 
scan to be reduced. Alternatively, using SENSE with the same acquisition time permits 
greater temporal or spatial resolution to be achieved. 
2.8.3.4  Delayed Enhancement Imaging 
This technique is used to visualise myocardium damage, such as scar or fibrosis. An 
intravenous contrast agent is administered most frequently as a chelate of gadolinium. This 
agent is extracellular. Therefore it is distributed into the intravascular and interstitial space, 
but does not penetrate healthy myocardial cells. Areas of acute or chronic infarction show 
higher signal than normal tissue. The inversion recovery technique is used to null the healthy 
myocardium – by suppressing the magnetisation, the tissue appears dark. The contrast agent 
accumulates in areas of damaged myocardium, an appears bright due to faster T1 relaxation. 
The distribution and percentage thickness of delayed enhancement can be used to assess 




2.8.3.5  Whole Heart 3-D Imaging 
This gives detailed anatomic information with whole heart coverage. The patient can breathe 
normally throughout the scan (free breathing). Scans are ECG gated to commence at mid-late 
diastole when the heart is relatively static. The timing of this acquisition is based on a 3 or 4 
chamber SSFP cine image. Artefact due to respiratory motion is avoided using a respiratory 
navigator, which is a visual marker positioned over the dome of the diaphragm. Data for 
image reconstruction are then only accepted during a limited window in the cardiac and 
respiratory cycles. This approach provides good signal to noise ratio and gives higher 
resolution images than breath-hold techniques. Nevertheless, due to relatively small window 
of acquisition, these sequences take several minutes to acquire.   
2.9  Left Atrial CMR Imaging 
Cardiac magnetic resonance (CMR) imaging is an imaging technique with excellent soft 
tissue contrast and provides high resolution two-dimensional (2D) and three-dimensional 
(3D) images. The use of paramagnetic contrast agents have previously established areas of 
cardiac pathology - tissue necrosis and inflammation within the left ventricle. 
78-81
 This is 
made possible through the poor washout kinetics of the contrast agent
78
. Areas of irreversible 
injury become visible under MRI following the administration of the contrast agent which are 
retained in these areas but are washed out faster in healthy areas, leading to a phenomenon 
known as delayed enhancement (DE) or late enhancement (LE). MRI is also sensitive to 
variations in water content, and thus is effective at the detection of oedema in the left 
ventricle. Numerous studies have demonstrated a linear relationship between T2 relaxation 
time and myocardial water content
82-86
.  Recent progress in motion correction leading to 




2.9.1 The role of pre-ablation CMR imaging 
Atrial fibrillation promotes atrial structural and electrical remodelling. Animal work has 
correlated areas of discrete low voltage with abnormal atrial tissue, including atrial scar. 
There are multiple mechanisms at work promoting the formation of scar in the fibrillation 
atrium and this is of clinical relevance as there is a well recognised correlation between the 
presence of pre-existing left atrial scar and procedural outcome following catheter ablation. 
However, this information is rarely available prior to an ablation procedure as the left atrial 
voltage distribution can only be accurately assessed by direct measurement made from within 
the chamber at invasive EP study. 
DE-CMR imaging of the left atrium allows for the quantification of pre-existing scar non-
invasively. Previous DE-MRI work has been performed extensively in the left ventricle to 
characterise tissue heterogeneity that can potentially increase arrhythmia initiation and 
ischaemic ventricles to differentiate hibernating myocardium from non-viable tissue. Recent 
advances in improved MR sequences and reconstruction software has allowed for the 
visualisation and analysis of LA tissue.  
There are some clear areas in which the clinical relevance of pre-ablation LA delayed 
enhancement imaging may be useful: (i) Global chamber quantification of scar and its 
regional distribution may inform the decision to ablate and the likelihood of success, (ii) 
knowledge of scar burden with co-existing different disease processes, (ischaemic heart 
disease, thyroid disease, hypertension, diabetes) may predict clinical outcome, (iii) the pattern 
of scar following previous left atrial intervention may predict sites critical to arrhythmia 
recurrence eg visible discontinuities in circumferential or linear ablation lesions and therefore 
inform ablation strategy (iv) scar information may inform choice to drug therapy, favouring 
“anti-remodelling” medication over anti-antiarrhythmic drugs as has been the case for 




atrial electrophysiology will improve our understanding of the role and mechanism of atrial 
fibrosis in AF. 
(i) Scar burden and AF disease progression 
Fibrillation and fibrosis is likely to be a bi-directional process. In animal models, increased 
AF occurrence is seen following experimentally induced atrial fibrosis.
87
 Similiarly, an 
increase in collagen -1 and fibronectin-1 in atrial tissue is seen following rapid pacing of 
cardiac myocytes.
88
 In human LA tissue obtained during cardiac by-pass surgery, increased 
tissue fibrosis has been documented in patients with AF.
89
 Quantifying this pre-existent 
fibrosis in-vivo non-invasively to assess the extent of AF disease progression is important. 
To-date, published work
90
 showing a lesser degree of delayed enhancement in patients with 
AF of shorter duration than in patients with long lasting persistent AF. This observation helps 
corroborate the link between the degree of fibrosis and disease severity. 
Whilst the association between atrial fibrosis and atrial fibrillation remains a combination of 
mechanisms, it is well accepted that more fibrosis means more severe disease.  This has led to 
the Utah staging system based on the increasing extent of pre-existing DE-LA  MRI.
90
 There 
are four stages in this system, Utah 1:  no or minimal fibrosis; Utah 2: 5-20%  fibrosis, Utah 
3: 20-35% fibrosis and Utah 4 more than 35% fibrosis in the atria. This classification system 
may have a potential role in tailoring treatment modality.  
(ii) Pre-existing scar and clinical response to ablation 
The greater the burden of scar and atrial fibrosis, the less the likelihood of functioning atrial 
myocardium. Oakes et al
90
 have demonstrated an association between increased areas of LA 
enhancement and AF recurrence following catheter ablation. Patients with a greater degree of 
delayed enhancement in the LA wall incur a higher recurrence rate. Not only was the amount 




LA posterior wall and septum had a better clinical outcome following catheter ablation 
compared to patients with enhancement in all portions of the LA. Larger similar multi-centre 
studies confirming the significance of pre-exisiting enhancement and procedural outcome 
data may allow this to be an independent prognostic marker for AF ablation .  The earlier 
described Utah staging system of left atrial DE can be a useful utility once validated in 
patient selection, especially in the persistent AF cohort. Candidates with a high pre-existing 
atrial scar maybe best served by medical optimisation. On the whole, better patient selection 
does translate into more optimum resource utilisation; leading to greater cost efficiency and 
reduced unnecessary patient procedural exposures. Patients can also be better advised on 
outcome possibilities, those with greater quantified areas of enhancement can have a reduced 
long term success expectation should they agree to proceed. 
(iii) Scar distribution following prior LA intervention 
Whilst some patients undergo ablation procedures with left atria that is naïve to previous 
radiofrequency energy delivery, a good number of patients have previously had an ablation 
either in the same centre or another one. In this case, establishing the lesion set achieved 
during the previous procedure may enable planning a better ablation strategy. DE MRI of the 
left atrium allows for this in-vivo visualisation of scar in relation to the anatomic structures. 
This gives the electrophysiologist  an idea of how much of the previous ablation procedure 
was successful in creating areas of intended scar and thus how much further ablation work 
that is necessary. The role of DE MRI in re-do procedures shall be discussed further in the 
subsequent section. 
(iv) Scar distribution and atrial electrophysiological characterisation 
Having established the role of delayed enhancement in assessing scar burden, and potentially 
playing a future role in patient selection, it would be appropriate to try and correlate various 




entail the quantification of scar within various regions of the atrium and assessing the 
electrical potentiality in these regions in the cardiac catheter laboratory prior to catheter 
ablation. Establishing a correlation between various MR signal intensity range to electrical 
activity may allow for an indirect way of electrophysiologically characterising areas of 
delayed enhancement into zones of electrical activity versus electrical inertia. 
Aside tissue characterization and delayed enhancement (fibrosis) quantification, basic 
anatomical data, volumes and function can be obtained.  Whilst LA anatomy is more often 
homogenous, PV anatomy heterogeneity is common. This non-pathologic variation does 
occur with a 30-40% incidence 
91
; the most common being a single left common pulmonary 
vein or an additional right pulmonary vein.
92
 
2.9.2  The role of post-ablation CMR imaging 
 Pulmonary vein antrum ablation is the cornerstone technique for catheter ablation in treating 
patients with PAF. This method involves delivery of radiofrequency energy in a wide 
encirclement pattern around ipsilateral pairs of pulmonary veins with subsequent completion 
of electrical isolation guided by a circumferential mapping cathether. Energy delivery this 
way creates scar barriers between the PV and the left atrium.  Areas of tissue injury following 
catheter ablation can be visualised using delayed enhancement CMR. A correlation between 
the presence of  greater DE post ablation and a better clinical outcome has been established.
93
 
2.9.3  Re-do catheter ablation procedures 
Electrical reconnection of the PVs to the LA is common following AF ablation and can occur 
in up to 80% of cases. 
94, 95
 This is thought to account for the majority of cases of AF 
recurrence. 
96
 Recurrences also may arise due to gaps within the pulmonary vein antrum 
lesion set due to incomplete encirclement. Pulmonary vein antrum isolation is a technically 




Left Atrium (LA)-Pulmonary Vein(PV) structure. Conventional fluoroscopy uniformly used 
for real time visualization of catheter position only provides a two-dimensional 
representation, resulting in the possibility of some anatomic variations being inadequately 
visualized. Despite the use of electroanatomic mapping systems, precise catheter location can 
be affected by both the beating heart and respiratory motion, impacting on accuracy and 
spatial referencing within the three-dimensional mapping systems .
97 
Post ablation DE MR scans suggests that a continuous complete circumferential encirclement  
around the pulmonary vein is infrequently achieved.
98
 These CMR scans have the potential to 
providing a road map to areas of successful scar formation following energy delivery and 
lesion creation. This in return allows for the identification of gaps in lesion sets which can be 
useful in planning further subsequent ablation procedures. Anatomical targets observed on 
these CMR scans may assist in developing a catheter ablation strategy in cases with 
recurrences. Importantly, the completion of conduction gaps during repeat procedures have 
proven to eliminate further arrhythmias recurrence.
98, 99
 This information can be used together 
with electrophysiological findings during catheter ablation to understand the relationship 
between ablation lesion sets and post-ablation arrhythmias. Further imaging can be performed 
to confirm the completion of these gaps following the repeat procedure. 
 
2.9.4  Correlating points on mapping systems to MR ablation lesions 
Electro-anatomic mapping systems have emerged to help locate the substrate for cardiac 
arrhythmias and to guide ablation. These consist of data acquisition and display systems that 
analyse acquired electrical signals, determine the location of the catheter tip and use the 
gathered anatomical and elecrophysiological data to generate 3D electroanatomical maps.
100
 




inaccurate. Typically, the points at which ablation energy is delivered are marked on the map 
when there is a reduction in the local electrogram voltage, but this does not necessarily 
establish the creation of a permanent ablation lesion or continuous ablation line.
101
 The 
degree of contact between the ablation catheter tip and atrial wall as well as wall thickness 
are likely to be important factors in forming adequate ablation lesions but are poorly assessed 
by fluoroscopy or electro-anatomical mapping systems.
102
 Integration of images obtained 
from CT can improve soft tissue delineation but have been shown to be inaccurate when a 
system-independent assay of accuracy is performed.
103
 
Recent developments in computer software and programming have allowed for overlaying 
CMR or computed tomographic anatomical data with electrophysiological anatomical data. 
This has been driven by the prospects of improved anatomy depiction which in turn may 
translate in increasing more effective ablation delivery whilst reducing procedure time and 
radiation dose. Whilst ablation points are recorded on the EAM system, however the efficacy 
of each ablation point is difficult to determine during the procedure. 
Utilising LA MR imaging and using custom designed registration computer software, 
intended points of ablation on the EAM system can now be evaluated against the actual late 
enhancement (scar) areas on the MR scan.  Recent work comparing ablation points on 
CartoBiosense Webster and the  LE images has demonstrated both a good registration 
between the Carto surface points and the MRA surface.
104
 Whilst an average distance of 
3.6±1.3mm between Carto ablation points and LGE scar was recorded, 20% of sectors with 
sites of Carto ablation showed no evidence of LGE. 
The use of this utility now allows the possibility of assessing current mapping tools and 




2.9.5  Potential future roles 
The role of inflammation is now increasingly being implicated in the initiation and 
perpetuation of AF. 
105
This has been corroborated by various inflammatory markers including 
CRP 
106
, IL-1, IL-6 and TNF-alpha. 
107
 This inflammation may lead to atrial remodelling and 
long term fibrosis. Whilst the exact mechanism of inflammation initiating and perpetuating 
AF can only be speculated, medications such as statins and ACE-inhibitors are being used in 
primary and secondary prevention of AF. 
MR imaging can offer a potential role in assessing LA reverse remodelling, qualifying and 
quantifying reduction in DE (fibrotic areas) whilst calculating functional parameters such as 
atrial ejection fractions. In vivo data of the extent of disease modification can be closely 
studied and similarly the therapeutic effects of other pharmaceutical agents can also be 
followed- through. 
Also, new catheter ablation tools can be studied using MR imaging. Both the quality and 
character of lesions delivered in-vivo can be assessed. The use of newer materials utilised in 
catheter design (eg. gold), catheter shapes and dimensions which may confer unique ablation 
lesion set patterns can be studied. In this way, devices that favourably promote more scar 
formation can be assessed in vivo in humans for the first time. Simultaneously, alternative 
energy sources may also be assessed. 
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3 General Methodology 
Patients 
The St Thomas’ Hospital local ethics committee approved the studies (Appendix 1).  All 
patients provided written informed consent. Studies were performed in compliance with the 
Declaration of Helsinki. 
3.1 Patient selection 
3.1.1 Inclusion Criteria 
a) Patient has documented symptomatic paroxysmal AF whilst taking one or more anti-
arrhythmic medication. 
b) Paroxysmal AF of at least 3 months duration. 
c) Between 18 and 75 years of age  
e) Patients of childbearing potential must have a negative pregnancy test (within 7 days of the 
procedure)  
f) Patient must provide written informed consent. 
g) Patient is willing and able to comply with the follow-up protocol  
3.2.2 Exclusion Criteria 
a)  AF associated with a recent unstable cardiovascular status (i.e. ischaemic chest pain or 
haemodynamic instability). 
b)  Medical condition unknown to worsen or precipitate AF (eg hyperthyroidism) that is not 
under current stable medical treatment. 
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c)  Previous Pulmonary Vein Isolation. 
d)  Contraindications for an MR scan (eg implanted metallic prosthesis, pacemakers) 
e)  Significant renal impairment (eGFR<30ml/min/1.73m
2
) 
f)  Cardiac surgery during the previous 3 months, myocardial infarction within 6 weeks or 
having unstable angina. 
g)  History of pulmonary stenosis (with or without symptoms). 
h)  Known or suspected coagulopathy or bleeding diasthesis. 
i)  Contrast allergy. 
j)  Presence of an intra-cardiac thrombus on a pre-procedure TOE. 
k)  Contraindication or an inability to comply with long-term anticoagulation therapy. 
l)  History of stroke or TIA in the last 3 months 
m)  Left atrial dimension of >5.5cm 
n)  History of inability to obtain vascular access and/or transseptal puncture is 
contraindicated.   
o)  Evidence of sepsis or acute metabolic illness 
3.2  Qualifying Baseline Assessments 
The following baseline assessments were performed to determine the presence of atrial 
fibrillation and eligibility to enter the study: 
 Medical history, including documentation of AF, previous anti-arrhythmic 
intervention/therapies and anti-arrhythmic medication history. 
60 
 
Chapter Three-General Methodology  
 Routine Haematology, Biochemistry and Clotting Profile 
 Standard 12 Lead ECG 
 Cardiac MR scans 
 Perform or retain documented Trans-oesophageal echocardiogram (TOE) to exclude 
the presence of LAA thrombus in patients who at risk of it based on the CHADS2 
score system. A score 2 and greater will qualify a patient for  a TOE. 
 Perform or retain documented Transthoracic Echocardiogram (TTE) [completed 
within 3 months prior to procedure] to evaluate standard structural measures – 
ejection fraction, LA size and valve measurements] 
Transoesophageal echocardiogram (TOE) were performed in patients who required it (i.e. 
CHADS2 score 2 and above) within 24 hours of scheduled procedure if the INR was 
measured at <2 at anytime in the preceding 4 weeks. If the TOE showed the presence of an 
intra-cardiac thrombus, the patient was excluded. 
Urine or serum pregnancy test was performed within 24 hours prior to the scheduled 
procedure as appropriate. Patients confirmed pregnant were excluded from the study. 
Patients were stabilised on warfarin with INR > 2.0 4 weeks prior to the procedure. 
3.3 Catheter Ablation 
3.3.1  Set up 
All ablation procedures were performed at St Thomas’ EP catheter laboratory. Patients were 
attached to standard haemodynamic monitoring and electrocardiographic equipment. RF 
generator ground pads will be securely attached to the patient’s skin with a sufficient quantity 
of conductive gel. Conscious sedation anaesthesia was administered accordingly to standard 
institutional practice.  
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3.3.2  Access, Anti-coagulation and 3-D left atrial maps 
Intravenous access was achieved via both right and left femoral veins. A 6F decapolar 
catheter was placed in the coronary sinus to provide a reference for electroanatomic mapping 
and to enable LA pacing. Double transseptal punctures from the right femoral vein was 
performed manually and access to the left atrium was obtained using 8.5Fr non-deflectable 
long sheaths, (St. Jude Medical Inc., St. Paul, MN, USA). Patients with a Patent Foramen 
Ovale (PFO) had the transseptal systems placed through the PFO. Following the first 
transseptal puncture, intravenous heparin bolus was administered to achieve an activated 
clotting time of between 300 and 400 seconds. Both circular mapping catheter 
(Inquiry™Optima™, St. Jude Medical Inc.) and  NaviStar® ThermoCool® 3.5 mm irrigated 
tip catheter (Biosense Webster Inc., Diamond Bar, CA, USA) were employed to create a 3-
dimensional geometry of the left atrium with either NavX™ (St. Jude Medical Inc., St. Paul, 
MN, USA) or CARTO XP (Biosense Webster Inc., Diamond Bar, CA, USA).   transeptal 
puncture to the left atrium performed in the standard way.  
All sheaths and guiding catheters were aspirated and flushed with heparinised saline to 
remove all air prior to any catheter insertion or removal. A continuous heparinised saline drip 
was used at a rate that will ensure luminal patency and prevent clot formation in all sheaths. 
ACTs were measured regularly, and subsequent heparin boluses were administered 
accordingly to achieve a target range of between 250-350 seconds.  
3.3.3 Pulmonary Vein Encirclement 
All pulmonary veins were isolated using the wide area pulmonary antral circumferential 
ablation (WACA) approach.  The circular mapping catheter was placed in each pulmonary 
vein in turn while the corresponding LA-PV antrum was targeted with wide area 
circumferential ablation. Pulmonary vein isolation was confirmed by the lack of potentials in 
the pulmonary veins or the presence of dissociated PV potentials. Ablation lesions were 
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marked on the LA geometry when there had been an 80 % reduction in the local electrogram 
voltage or after 30 seconds of energy delivery. One tag was applied to the shell per 30s RF 
energy delivery and a standard tag size was used throughout the study. If LA-PV conduction 
persisted despite wide area circumferential ablation, additional lesions were delivered at sites 
of earliest activation on the circular mapping catheter until entry block in all 4 veins was 
confirmed by observing the elimination or dissociation of pulmonary vein potentials. Exit 
block was not routinely assessed. Neither adenosine nor isoprenaline was routinely 
administered to test the integrity of PVI or to search for non-PV triggers of AF. No linear 
ablation was performed in patients with paroxysmal AF. 
3.3.4 Tissue Contact Assessment 
The ablation catheter was observed on the fluoroscope and mapping system display to 
confirm correct positioning. Bipolar electrical signals was observed from the electrode 
catheter. For manual procedures, sharp electrograms with high frequency signal components, 
low electrical noise and large relative signal amplitudes, together with operator assessment, 
was used to  indicate good contact. For robotic procedures, these indicators was used in 
conjunction with Intellisense readings. Intellisense will be targeted in the 20-30g range.
18, 19
 
3.3.5  Tissue Ablation 
In both Hansen Robotic Assisted and Standard Catheter ablation groups, energy was 
delivered until local electrograms were attenuated.  In the Hansen group the power, duration 
and force settings of between 15-30W at the intellisense range of 20-30g (recommended not 
above 40g) were applied.  In the manual group, 60 scond applications were delivered at 
power settings between 40-60W. Force applied was operator dependent accordingly.  
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3.4  Cardiac MRI 
3.4.1 Acquisition 
CMR scans were performed on a 1.5 Tesla Philips Achieva MR system (Philips Healthcare, 
Best, Netherlands), using initially a 5 channel and then moving onto the 32 channel surface 
coil (Invivo, Orlando, Florida, USA).  
3.4.2  Interactive planning 
 
Figure ‎3-1: Interactive planning of cardiac MR in one of the study  patients. 
 
The cardiac MR examination began with a survey and reference scans, and an interactive 
scan to determine the four-chamber orientation of the heart. Interactive imaging was 
performed using rapid SSFP sequences to manipulate the geometry of the imaging plane.This 
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allowed planning of the geometry to be used in subsequent sequences. Four viewing windows 
were used to show theactive imaging plane as well as its relationship to three previously 
acquired images, with the active imaging plane depicted by a line in these images. The line in 
any of the three images couldbe moved in order to change the angle of the active imaging 
plane itself. In addition the active imaging plane could be displaced in parallel planes to that 
which is showing the “push/pull” function. Geometrics were stored for use later in the MR 
examination. 
3.4.3  2D-Cine 
 
Figure ‎3-2: An example of a 2D cine scan acquired in the four chamber orientation that is used to 
determine the trigger delay time  
 
A 2D cine scan was performed to acquire the four chamber orientation to determine the time 
after the R-wave at which atrial motion was at a minimum, commonly found at ventricular 
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end-systole. All subsequent ECG triggered scans was set to the trigger delay time determined 
from the cine, to reduce cardiac motion and optimise image acquisition. 
3.4.4  T2-Weighted Imaging 
 
Figure ‎3-3: T2-Weighted imaging acquired using multi-slice Turbo Spin Echo (TSE) with double 
inversion recovery (DIR). 
 
T2-Weighted images were acquired using a multi-slice Turbo Spin Echo (TSE) acquisition 
technique with a double inversion recovery (DIR) pre-pulse for black-blood imaging. Spatial 
pre-saturation with inversion recovery (SPIR) fat suppression was used. Echo time used was 
set at 120ms to the centre of k-space using a linear profile ordering. Image resolution was set 
at 1.5x1.5mm2 with a slice thickness of 5mm. The number of slices was set accordingly to 
provide complete coverage of the left atrium, approximately 20-25 slices. Image acquisition 
was programmed to occur at every second R-wave. To minimise differences in respiratory 
phase between slices, image acquisition was respiratory navigated. 
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3.4.5  Magnetic Resonance Angiography (MRA) 
 
Figure ‎3-4: An example of 3D magnetic resonance angiography (MRA) following 0.04ml/kg Magnevist 
 
For anatomical information a 3D magnetic resonance angiography (MRA) scan was acquired 
following contrast agent injection. This scan did not require ECG gating. A gadolinium-based 
contrast agent (gadopentetatedimeglumine–Magnevist, Bayer Health Care) was administered 
intravenously. A dose of 0.04ml/kg was given according to body weight. Importantly, 
patients with renal impairment were excluded from the study as administration of a contrast 
agent in a patient with renal failure is a relative contraindication as there is an increased risk 
of nephrogenic systemic fibrosis. A Glomerular filtration rate of <30ml/min/1.73m
2 
was set 
as a cut off for exclusion. 
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3.4.6 Whole-Heart 3D Imaging 
 
Figure ‎3-5: Whole heart imaging performed in sagittal orientation  using a 3D balanced steady state free 
precession (b-SSFP)  
 
This was followed by a 3D balanced steady state free precession (b-SSFP) acquisition in a 
sagittal orientation with whole-heart coverage and 2.7mm isotropic resolution and T2 
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3.4.7 Delayed Enhancement Imaging 
 
Figure ‎3-6: Delayed enhancement imaging were acquired using a free breathing inversion recovery (IR) 
turbo field echo (TFE) with both respiratory navigation and ECG triggering. 
 
The scan for the visualization of delayed enhancement was a respiratory navigated 3D ECG-
triggered, free breathing inversion recovery (IR) turbo field echo (TFE) with a pixel 
resolution of 1.3x1.3x4mm3, which was subsequently reconstructed to 2mm slice thickness. 
 Data was acquired with in a window of 150ms at every 1RR interval, with a low-high k-
space ordering and SPIR fat suppression. The IR delay time was determined from the Look-
Locker sequence and set at a TI intermediate between the optimal TIs to null myocardium 
and blood. 
 This nulling has been performed by our CMR group and has resulted in the most efficient 
visualisation of the late enhancement signal from the necrotic tissue. This scan was 
performed approximately 25-30 minutes following contrast agent administration. A 
gadolinium-based contrast agent (gadopentetatedimeglumine – Magnevist, Bayer Health Care 
) was administered intravenously. The number of slices was set for complete coverage of the 
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left/right atria (typically 30-40 slices). Slice orientation was in the four chamber view to 
optimise visualization of the PVs. 
 
3.5  Image Processing 
A major aim of this study was to quantify PV antrum percentage encirclement on CMR to 
assess tissue necrosis by delayed enhancement (DE), tissue oedema by increased T2 
enhancement (T2) and combination of tissue necrosis and oedema (DE&T2).  
To achieve this, a novel automated 3D method for visualizing and quantifying myocardial 
injury following ablation was developed 
16
. First, the left atrium was semi-automatically 
segmented from the MRA by using the ITK Snap software 
17
. This uses a combination of 
thresholding and region growing for segmentation. Utilising in-house software built on  the 
Visualisation Toolkit libraries (VTK, KitwareInc), a left atrial surface was generated using 
marching cubes alogorithm. This was then fused with the delayed enhancement or T2-
weighted images using intensity-based image registration. The vectors perpendicular to the 
surface at each vertex were computed and a maximum intensity projection (MIP) of the 
image intensity values in the DE or T2-weighted images was performed along each normal 
vector at a length of +/- 3 mm from the surface. The LA surface was then colour coded 
according to the MIP values, ranging from green (minimum) to red (maximum). Areas of DE 
or high T2 signal intensity were defined as being more than three standard deviations above 
the mean signal intensity of an area of healthy myocardium distant from the ablation target 
sites (usually defined in the left ventricular myocardium) 
These 3D MR reconstructions were analyzed independently by two experienced readers. Both 
readers assessed all image data twice. The % delayed gadolinium enhancement (DE), high T2-
weighted signal (T2) and combination of delayed gadolinium enhancement and T2 (DE+T2) 
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encircling the pulmonary veins was estimated on visual inspection. Source images were also 
analyzed to ensure that the degree of enhancement or high T2 signal detected by our automated 
method was accurate.  
 
Figure ‎3-7: (a) Fusion of MRA-derived surface of the LA with the delayed- enhancement image acquired 
in the four-chamber view. (b) Close-up of the surface fused with the delayed-enhancement image and 
arrows indicating the direction in which the MIP is taken. (c) Projection of the MR signal intensities onto 
the surface shell. The higher the signal intensity, the brighter the surface shell colour. (d) NavX shell 
geometry with the corresponding ablation lesions placed.  On visual assessment, a good correlation is 
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4 Acute and Chronic Cardiac Magnetic Resonance Imaging Following 
Atrial Fibrillation Catheter AblationIntroduction 
Paroxysmal atrial fibrillation (AF) is often triggered by spontaneous ectopic beats of 
pulmonary venous origin,
12
 an observation which has led to the emergence of pulmonary vein 
isolation (PVI) as an effective treatment for AF. Typically, ablation is performed at the left 
atrial-pulmonary vein (LA-PV) junction,
108, 109
 with the intention of causing acute tissue 
necrosis to eliminate conduction between the LA and PVs. Clinical recurrences of AF 
following catheter ablation are common and recovery of LA-PV conduction ubiquitous in 
patients with and without documented AF during follow-up.
94
 Single procedure success rates 




Delayed enhancement MRI following the administration of gadolinium has been used 
extensively to image ventricular scar after myocardial infarction secondary to coronary 
occlusion.
111
 More recent work has demonstrated the potential utility of cardiac magnetic 
resonance imaging (CMR) for assessment of atrial fibrosis prior to ablation and of atrial 
injury following ablation.
98, 112
 Although gadolinium diffuses into the intracellular space 
following the loss of cell membrane integrity associated with acute tissue destruction, it can 
also accumulate acutely in the increased extracellular space created by myocardial edema, 
which may represent a reversible form of cardiac injury and is therefore not specific to 
necrotic tissue.
113
 An alternative method to visualize myocardial edema uses the linear 
relationship between T2 relaxation time and myocardial water content, and may be a more 
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The aim of the study was to use DE- and T2-weighted CMRI to characterize the tissue 
effect of left atrial ablation and to relate the pattern of acute atrial injury to clinical outcome. 
We hypothesize that acute PVI is caused by a combination of irreversible tissue destruction 
and reversible tissue injury at the LA-PV junction. 
4.2  Methods 
4.2.1 Patient population  
Twenty-five patients (17 male, mean age 55±11 years) with symptomatic, drug refractory 
paroxysmal AF undergoing their first PVI completed the study. 29 patients were consented  
for the study but four were excluded (3 because of claustrophobia with failure to complete 
scan and 1 due to an ineffective respiratory navigator ). All scans used for the purposes of 
data analysis were deemed of adequate quality for analysis by an experienced CMR operator.. 
Therapeutic anti-coagulation with an INR >2 for at least 4 weeks prior to the procedure was 
mandated. The study was approved by the Local Research Ethics Committee. 
Acute procedural success was defined as PVI confirmed using a circumferential 
mapping catheter. Clinical outcomes are reported at 6 months follow-up. Patients were 
followed in clinic to assess symptoms. 24 hour-Holter monitors were performed at 6 months. 
Every effort was made to obtain ECG recordings of symptomatic recurrences. Recurrences 
were defined on the basis of 1) symptoms with ECG evidence of the presence of atrial 
fibrillation/flutter/tachycardia or 2) the presence of symptomatic or asymptomatic episodes of 
atrial arrhythmia lasting for >30 seconds on ambulatory cardiac monitoring. 
4.2.2 MR Image acquisition 
All participants underwent MR imaging in a 1.5 Tesla Philips Achieva MR system (Philips 
Healthcare, Best, Netherlands) using either a 32 channel surface coil (Invivo, Orlando, 
Florida, USA) or a large two-channel flex coil.  
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T2-weighted images were acquired using a multi-slice Turbo Spin Echo (TSE) 
acquisition technique with a double inversion recovery (DIR) pre-pulse for black-blood 
imaging. Spatial pre-saturation with inversion recovery (SPIR) fat suppression was applied. 
The echo time used was set at 120ms with a linear profile ordering.  This enabled the image 
resolution to be set at 1.5x1.5mm
2
 with a slice thickness of 5mm. The number of slices was 
set to provide complete coverage of the left atrium (20-25 slices). Diaphragmatic motion was 
tracked and respiratory motion correction applied to minimize motion blurring and 
differences in respiratory phase between slices during image acquisition. 
 To visualize DE, a 3D ECG-triggered, free-breathing inversion recovery (IR) turbo 
field echo (TFE) scan with respiratory navigator motion correction was performed with a 
pixel resolution of 1.3x1.3x4mm
3
, which was then reconstructed to 1.3x1.3x2mm
3
. Data were 
acquired at mid-diastole with a 150ms acquisition window and a low-high k-space ordering 
as well as SPIR fat suppression. The IR delay time was determined from a Look-Locker 
sequence and was set at a TI intermediate between the optimal TIs to null myocardium and 
blood. Previous work has validated this method for reproducible visualization of the late 
enhancement signal from necrotic tissue.
115
 DE scans were performed 20 minutes following 
contrast agent administration. The number of slices was set for complete atrial coverage (30-
40 slices). To optimize visualization of the PVs, slice orientation was performed in the four-
chamber view. Images obtained with this method appear to reflect the pulmonary veins at 
their maximal size. Similar MR sequences were used for images acquired (i) prior to ablation, 
(ii) within 24 hours of ablation and (3) 3-6 months following ablation. 
4.2.3 Ablation procedure 
A 6F decapolar catheter was placed in the coronary sinus to provide a reference for 
electroanatomic mapping and to enable LA pacing. Two transseptal punctures were made and 
access to the left atrium was obtained using 8.5Fr non-deflectable long sheaths, (St. Jude 
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Medical Inc., St. Paul, MN, USA). Following the first transseptal puncture, intravenous 
heparin was administered to achieve an activated clotting time of between 300 and 400 
seconds.  A 3-dimensional geometry of the left atrium was created using either NavX™ (St. 
Jude Medical Inc., St. Paul, MN, USA) or CARTO XP (Biosense Webster Inc., Diamond 
Bar, CA, USA). A circular mapping catheter (Inquiry™Optima™, St. Jude Medical Inc.) was 
then placed in each pulmonary vein in turn while the corresponding LA-PV antrum was 
targeted with wide area circumferential ablation. Energy was delivered through a NaviStar® 
ThermoCool® 3.5 mm irrigated tip catheter (Biosense Webster Inc., Diamond Bar, CA, 
USA) with flow limited to 17 ml/min, power limited to 30 W on the anterior wall and 25 W 
on the posterior wall and temperature limited to 50
0
C. Ablation lesions were marked on the 
LA geometry when there had been an 80 % reduction in the local electrogram voltage or after 
30 seconds of energy delivery. One tag was applied to the shell per 30s RF energy delivery 
and a standard tag size was used throughout the study. If LA-PV conduction persisted despite 
wide area circumferential ablation, additional lesions were delivered at sites of earliest 
activation on the circular mapping catheter until entry block in all 4 veins was confirmed by 
observing the elimination or dissociation of pulmonary vein potentials. Exit block was not 
routinely assessed. Neither adenosine nor isoprenaline was routinely administered to test the 
integrity of PVI or to search for non-PV triggers of AF. 
4.2.4 Image processing, analysis and its validation 
Using CMR, this study sought to quantify the extent of PV antral encirclement as 
demonstrated by DE- and T2-weighted CMRI, individually and combined. To achieve this, 
an automated 3D method for visualizing and quantifying myocardial injury following 
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Figure ‎4-1:.(a) Raw MR scan image of the LA and PVs showing areas of delayed enhancement. (b) Fusion 
of the MR derived 3-D LA shell into the delayed-enhancement image. The red arrows indicate the 
direction in which the maximum intensity projection (MIP) is taken. (c) Projection of the MR signal 
intensities onto the surface shell. The surface shell colour is set within a range going from green to yellow 
to red corresponding with low to high signal intensity. (d) 3-D colour LA shell harvested from the 
delayed-enhancement MR image. 
 
3D-MR reconstructions were analyzed independently twice by two experienced readers, 
blinded to clinical outcome and to the timing of the scan following catheter ablation. T2 and 
DE signal circumferential quantification was performed by reconstructing all CMR scans into 
individual left atrial shells . PVs were analyzed as ipsilateral pairs for each of the 25 patients 
at three time points, permitting analysis of 150 PV pairs. For each PV pair, T2 and DE was 
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quantified as occupying a percentage of the antral circumference.  Percentage delayed 
gadolinium enhancement (DE), high T2-weighted signal (T2) and combination of delayed 
gadolinium enhancement and T2 (DE+T2) encircling the pulmonary veins was determined 
independently by both readers and consensus reached. A high degree of interobserver 
agreement was seen on a Bland Altman test with a maximum observed difference of 10% 
seen. The mean±SD inter-observer error for DE, T2 and DE&T2 was 1.5±2.5%, 1.5±3.5% 
and 0.8±2.2% which was acceptable for the purposes of data analysis.  
4.2.5 Statistical analysis 
Summaries for continuous variables are expressed as mean ± confidence interval. Follow-up 
times are reported as the median and interquartile range (IQR).Categorical variables were 
compared among recurrences and non-recurrences groups using a chi-square test. The % 
circumferential encirclement by DE, T2 and DE&T2 groups were compared to test for 
differences between group means. Statistical analyses were performed using Stata (StataCorp 
2009). A linear regression model with predictor (code 1 for no recurrence and 0 for 
recurrence) and outcome T2, DE, T2&DE, DE/(T2&DE) respectively was applied and run in 
Stata. We used the vce (cluster subject) option in Stata
116
  to allow for inter-subject 
dependence (left and right pulmonary vein measurements from the same patient). Analyses 
for acute and chronic pulmonary vein findings on cardiac MR were performed separately. A 
p value of less than 0.05 was considered statistically significant 
4.3 Results 
4.3.1 Patient and procedural data 
Table 4.1 outlines the baseline study population demographics. Successful pulmonary vein 
isolation was achieved in all patients.  Median follow-up time was 11 months (IQR 8 to 16 
months). A three month blanking period was observed during which arrhythmia recurrences 
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were treated with antiarrhythmic drugs or DC cardioversion. No repeat ablation was 
performed within the blanking period. Clinical recurrence of AF was documented in 11(46%) 
patients with a median time to recurrence of 94days (IQR 45 to 166 days).Patients with 
recurrences had significantly larger LA size and longer duration of AF. Seven of 11 patients 
with recurrences underwent a re-do procedure; two patients are awaiting a redo procedure 
and two declined further intervention.Procedural complications include two femoral venous 
haematoma which did not require intervention. No stroke, tamponade or oesophageal fistula 
occurred in this study and no pulmonary vein stenosis was detected on follow up MRI.  
Table ‎4-1Patient demographics categorized into no recurrences and recurrences  
at 6 month clinical follow-up. 
 All       Subjects    
n=25 






























LA size, cm           3.7±0.5 3.4±0.2 4.2±0.3 0.03 
LVEF, %                     55±5 60 50 0.29 
Hypertension 5 2 3 >0.10 
Valve Disease 1 0 1 >0.10 
History of smoking 1 1 0 >0.10 














Chapter Four-Acute and Chronic Cardiac Magnetic Resonace Imaging Following Atrial Fibrillation 
Catheter Ablation  
4.3.2 Pre-ablation MRI 
The circumferential burden of DE and T2 weighted signal  detected prior to any ablation ,  
was low in comparison with acute post-ablation imaging (figure 4.2 and figure 4.3) and did 
not occupy more than 5% of the PV circumference. Pre-ablation DE signal localised to the 
mitral annulus, a common finding due to the fibro-elastic nature of cardiac tissue at this site. 
T2 signal was largely observed around the atrial roof and this is likely explained by the 
imperfections arising from the MR-sequence. In Black-Blood sequence, residual bright blood 
signal is observed in areas of slow through-plane flow (e.g. in the apex of the ventricles). 
This problem has been reported in acute edema assessment in the ventricles following acute 
myocardial infarction 
117
. Overall the amount of T2 signal pre-ablation was very small. 
4.3.3 Post-ablation MRI 
All acute imaging was performed between 18 and 24 hours following catheter ablation. 
Figure 4.2 demonstrates the typical T2-weighted and figure 4.3 typical DE appearances in 
two patients before and after catheter ablation. The left atrial burden of DE and T2-weighted 
signal was significantly increased following catheter ablation in comparison with baseline. 
On the acute scans, DE signal was concentrated in the PV antral region while T2 signal was 
more widely distributed in the atrium, remote from sites of ablation. 
Individual analysis of the circumferential extent of both signal types revealed that T2-
weighted signal occupied 100% of the antral circumference in 5/50 PV pairs while DE signal 
did not achieve complete encirclement of any vein pair. There was no significant difference 
between the circumferential extent of DE signal around the LPVs (63.0±8.6%)and the RPVs
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Figure ‎4-2: Demonstrates a series of T2 signal images of the left atrium and pulmonary veins in two patients with arrows pointing towards regions of hyper-
enhancement in column 2. Baseline images in the first column show no significant T2 enhancement (tissue edema) compared to the acute post ablation images in the 
second column. The late scans in the third column shows the T2 signal becoming almost similar to baseline in the pre-ablation scans in column one. 
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Figure ‎4-3: Demonstrates a series of DE images of the left atrium and pulmonary veins in 2 patients with arrows pointing towards regions of hyper-enhancement in 
both columns 2 and 3. Baseline images in the first column show no significant DE signal (tissue injury/necrosis) compared to acute post ablation images in the 
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Individual analysis of the circumferential extent of both signal types revealed that T2-
weighted signal occupied 100% of the antral circumference in 5/50 PV pairs while DE signal 
did not achieve complete encirclement of any vein pair. There was no significant difference 
between the circumferential extent of DE signal around the LPVs (63.0±8.6%)and the RPVs 
(65.5±7.6%, p=0.67).Similarly, although the circumferential extent of T2 signal was greater, 
there was no significant difference between LPVs (82.8±8.4%) and RPVs (73.7±7.0%, 
p=0.31). 
 Combined analysis of DE and T2 signal, using reconstructed shells co-displaying both signal 
types, revealed areas of T2 enhancement to overlap and interdigitate with those areas of high 
DE signal intensity (figure 4.3).  Hence the sum of DE and T2 is 100% or less. For the LPVs, 
the circumferential extent of DE signal alone, T2 signal alone and the combination of both 
signal types was 63.0±8.6%, 73.7±8.4% and 89.3±4.9% respectively. For the RPVs, the 
circumferential extent of DE signal alone, T2 signal alone and the combination of both signal 
types was 65.5±7.6%, 82.8±7.0% and 91.3±5.6%respectively. Compared to DE alone, the 
combined DE and T2 signal was significantly greater for both left (p=0.009) and right 
(p=0.027) PVs. Complete antral encirclement with combined DE and T2-weighted signal was 
seen in 17/50 (34%) PV pairs at the acute scan.  
At the chronic follow-up scans, T2 signal had largely resolved (figure 4.4 and 4.5), while a 
decline in the extent of DE signal was seen. For the LPVs, the circumferential extent of DE 
signal decreased from 63.0±8.6% to 50.9±8.2% (p=0.016); for the RPVs, the circumferential 
extent of DE decreased from 65.5±7.6% to 47.6±8.5% (p=0.002). Discontinuities in areas of 
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Figure ‎4-4: (i)and (ii)  demonstrate a series of reconstructed 3-D left atrial shells to visualise T2 and DE 
signal in the corresponding patients shown in figures 4.2 and 4.3. The 3 columns represent the 3 time 
points: pre-procedure scans (prescans, column 1), acute post procedure scans performed within 18 to 24 
hours (column 2) and the late scans performed later than 3 months (column3). Quantification of these 
enhancements was performed as percentage encirclements of the left and right PV antra.  Row A depicts 
the raw intensities mapped on to the shells from the T2 and DE MR scans. Row B shows the 
corresponding T2 and DE 3-D shells that have been thresh-holded semi-automatically.  Red areas signify 
delayed-enhancement and blue areas signify T2 signal intensity. In row C, the combined enhancements of 
T2 and DE is seen together.  On the acute scans seen in column 2, gaps present within areas of red (DE) 
are filled in by areas of blue (T2).  In column 3, the blue (T2) and red (DE) signals resolve, with a greater 
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Figure ‎4-5: This scatter-boxplot shows a comparison of pre, acute and late T2, DE and combined T2&DE 
for both left and right pulmonary vein antrum. Each individual scatter plot represents the raw data for 
that specific group. The dots within each group have been dispersed horizontally to optimise visualisation 
and clarity. The boxplots on the other hand represent median (red line), 95% confidence intervals (yellow 
box) and 1 standard deviation  (blue box) An overall higher enhancement is seen in all 6 groups on the 
acute scans compared to the 6 groups on the chronic scans.  The % encirclement by T2 signal diminishes 
from above 75% to about 5% in keeping with reversible injury. The % encirclement by DE signal 
diminishes to a much lesser extent. Using a combination of DE and T2 signal,  the % encirclement 
decreases from 90% at the acute scans to approximately 50% at the follow up scan 
 
4.3.4 Recurrences of AF: relationship to MR assessment 
Both acute and late scan data were analysed into two groups according to the respective 
clinical outcome – those with and without AF recurrences. 100 pairs of PVs (50 acute, 50 
late) analysed previously were divided into two groups according to the presence or absence 
of a clinical recurrence of AF. Figure 4.6 summarises the percentage circumferential 
encirclement of DE, T2-weighted signal and the combination of DE &T2 around the left and 
right PV pairs by clinical outcome for both the acute and late scans. 
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Figure ‎4-6 :.This scatter-boxplot shows a comparison of percentage of PV encirclement according to 
clinical outcome no recurrence (NR) v recurrence (R) of AF  accounted for by T2 signal, DE signal and 
combined T2&DE at three time points: pre-ablation (Pre) immediately post (Acute) and follow up scans 
(Late). Each individual scatter plot represents the raw data for that specific group. The dots within each 
group have been dispersed horizontally to optimise visualisation and clarity. The boxplots on the other 
hand represent median(red line), 95% confidence intervals (yellow box) and 1 standard deviation  (blue 
box).  The absolute decline in DE is less for patients with no AF recurrence. 
 
On the acute scans, there was no difference in the combined DE&T2 signal between 
both groups with mean % encirclement of 88.7±5.4% (no recurrences) and 93.3±4.8% 
(recurrences). When DE signal alone was analyzed, a significantly higher mean percentage 
encirclement was noted in the AF free group (n=14; 28 pairs of PVs) compared to the group 
with recurrences (means±CI, 73.1±6.0% vs 54.5±9.1% respectively, p = 0.016). Conversely, 
the T2 signal was noticeably lower in the AF free group compared to the group with 
recurrences (means ± CI, 70.3±7.8%  vs  87.7±6.3% respectively, p = 0.038).With the 
combined areas of DE & T2 forming almost complete rings around the pulmonary veins, 
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ratios of DE to (DE &T2) were calculated (figure 4.7). Patients with no recurrences had a 
higher mean DE/(DE&T2) ratio compared to the recurrence group (0.82±0.12 vs 0.58±0.20; 
p=0.0001).  
 
Figure ‎4-7: Mean DE/T2&DE ratios quantified on the acute scans for patients with no recurrences versus 
those with recurrences. An overall higher DE/T2&DE ratio is seen in patients free from AF. 
 
On the late scans, DE was the predominant signal type seen and was significantly 
greater in the AF free group compared to the group with recurrences (61.0±5.7% vs 
34.7±7.3% respectively, p <0.0001). A comparison of the acute and late scan DE data in both 
groups showed a lower regression of this signal type in the AF free group (from 73.1±6.0% to 
61±5.7%, p=0.03) relative to the group with arrhythmia recurrences (from 54.5±9.1% to 
34.7±7.3% p=0.01).  
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(c)  
(d)  
Figure ‎4-8 The relationship between late scan  DE and individual ablation duration (a), energy delivered 
(b), average power (c) and temperature (d) settings has been divided here into no recurrences and 
recurrences. The absence of any trend between the individual parameter and the amount of late DE 
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4.4 Discussion 
The findings of this paper are: (1) Acute pulmonary vein isolation is not associated with 
complete circumferential injury as determined by cardiac MR imaging; (2) Increased DE and 
T2-weighted signal are both seen within 24 hours of left atrial catheter ablation; (3) T2-
weighted signal has largely resolved by 3 months of follow-up, supporting its use as a marker 
of acute, reversible atrial injury; (4) In patients with clinical recurrences, a greater proportion 
of the acute circumferential antral injury is accounted for by T2-weighted signal than in those 
patients who remain arrhythmia-free 
Previous work evaluating the role of CMR in LA assessment post catheter ablation 
has focused on delayed enhancement imaging delineating areas of scar pre and post ablation. 
98, 112, 118, 119
 However MR imaging of acute, reversible atrial injury following catheter 
ablation has only been recently reported.
120, 121
There is evidence from animal studies that 
tissue edema causes right atrial wall thickening following linear ablation in the right 
atrium.
122
Left atrial edema most likely occurs during and immediately after AF ablation as 
evidenced by an increase in atrial wall thickness, and resolves within one month.
123
 During 
late-gadolinium MRI performed immediately after ablation, both non-enhancing and hyper-
enhancing tissue types are seen, the former of which is a poor predictor of scar visualized at 3 
months follow-up.
121
 This is likely to reflect ablated but not necessarily necrotic tissue 
confirming previous work, including that from our own laboratory, that DE MRI 
overestimates the acute extent of tissue injury following left atrial catheter intervention by 
virtue of the accumulation of gadolinium in extravascular water associated with acute 
inflammation. Although there is a good correlation between endocardial voltage-defined scar 
and T2 weighted signal immediately post ablation, there is a poor correlation with the DE 
MRI-defined scar at three months follow up 
124
, further supporting the transient nature of at 
least part of the ablation injury process.  
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T2 signal was found in the acute CMR scans remote form the ablation sites. Similar 
observations have previously been described. 
124
 This is most likely related to a cytokine (IL-
6) mediated inflammatory response following radiofrequency ablation. 
125
 Another possible 
mechanism giving rise to this observation may be related to sheer/rotational force of the 
catheters against the atrial wall during catheter manipulation.  
4.4.1 Acute PVI and atrial ablation injury 
The data presented in this paper demonstrate a high circumferential extent of each of T2 and 
DE signal within 24hours of ablation. While this is consistent with a high degree of overlap 
of the two imaging signal types, there are also some areas where T2 signal can be detected in 
the absence of DE signal and vice versa . By overlaying DE and T2 weighted images on the 
same anatomical shell, we have demonstrated that the circumferential extent of ablation 
injury is greater when both signal types are summated, reaching approximately 90%. 
Although 100% circumferential extent of combined T2 and DE signal was seen in only 17 of 
50 PV pairs, it is well known that acute PV isolation can be achieved using a segmental, 
electrogram-guided approach rather than a circumferential ablation approach, the former of 
which does not necessarily result in ablation of the entire PV circumference.
58
 This may 
explain the finding that PV isolation can be readily achieved without circumferential MR 
evidence of ablation injury. 
4.4.2 Atrial scar and arrhythmia recurrence 
The MR data at the follow up scan demonstrate near-abolition of T2 signal while DE signal is 
reduced and continues to occupy only 60% of the circumferential extent of both pairs of 
pulmonary veins. This is in keeping with the finding that chronic pulmonary vein 
reconnection is ubiquitous following conventional wide area circumferential ablation and 
indeed was seen in all AF recurrences in this paper.
94, 96
 In the present study, a greater extent 
of circumferential DE signal at the 24h scan was predictive of freedom from AF while the 
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extent of T2 signal was greater in the arrhythmia recurrence group. While there is a lack of 
clarity of what DE and T2 signals truly represent in the immediate aftermath of a catheter 
ablation procedure, the presence of DE signal beyond three months follow-up is likely to 
represent permanent atrial scar.
121, 126
 
The decline in circumferential extent of DE signal between acute and follow up scans 
was less for patients with no AF recurrence than for those patients in whom AF recurred. 
This supports our hypothesis that the greater the contribution of T2 signal, representing 
reversible injury, to acute PVI, the higher the likelihood of PV reconnection following 
resolution of tissue edema.  
Although preliminary work has demonstrated a qualitative correlation between 
discontinuities in areas of high DE signal and conduction gaps on electrophysiology study
98, 
99
, pulmonary vein reconnection also occurs in patients without clinical arrhythmia 
recurrence
95
 and therefore caution must be exercised in relying on the use of MR-defined scar 
as a surrogate for electrophysiological reconnection. 
4.4.3 Potential Clinical Significance 
It has been previously shown that durable radiofrequency lesion formation is dependent on 
parameters including catheter tip electrode size, power, catheter tip temperature and contact 
force. The presented data suggest that there is an element of reversible myocardial injury 
during ablation. Ablation strategies and techniques which favourably alter the necrosis/edema 
ratio such as alternative energy sources, contact pressure sensing and improved catheter 
stability may minimise reversible myocardial injury.  
4.4.4 Study limitations 
There are significant limitations to MR imaging of the left atrium following catheter ablation 
with no widely accepted standardisation of technique between laboratories.  
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Whilst there is evidence from animal studies that gadolinium is predominantly a 
marker for tissue necrosis, by virtue of its kinetics, it also accumulates in extracellular water 
which is also seen in acute inflammation. In addition, while T2 MRI can preferentially 
represent myocardial edema, there is currently no robust histological evidence corroborating 
this in the atria following radiofrequency ablation. 
Although the DE and T2 signal recorded acutely following ablation almost certainly 
include some “double counting” of edema and necrosis by both techniques, the near complete 
resolution of T2 signal at follow up indicates that at the very least, T2 predominantly 
represents some form of reversible atrial injury.  
The annotation of lesions on an electroanatomic map is subjective and likely does not 
accurately reflect the site of atrial injury, which may explain in part the unanticipated MR 
finding of PV encirclement in only 36% of PV pairs. We attempted to mitigate this by using a 
point-by-point technique, with RF applications of 30 seconds and 1 tag per application. 
Detection of asymptomatic recurrences of AF without the use of continuous 
monitoring is impossible. Because of the frequency of monitoring, it is likely that the 
incidence of asymptomatic AF is underreported in the current study. 
This is a small, hypothesis-generating study and the utility of necrosis and edema 
imaging as a predictor of longer-term clinical outcome would require a larger study for 
validation. 
4.5  Conclusion 
Acute pulmonary vein isolation is achieved by a combination of reversible and irreversible 
circumferential tissue injury at the PV-LA junction. The greater the ablation extent accounted 
for by reversible injury, the higher is the incidence of AF recurrence.
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5 Technology Assessment of Atrial Fibrillation Catheter Ablation by 
Cardiac Magnetic Resonance Imaging 
5.1 Introduction 
Arrhythmia recurrences following pulmonary vein isolation in paroxysmal atrial fibrillation is 
almost universally associated with electrical reconnection between the left atrium and 
pulmonary veins 
94
. Acute PV electrical isolation achieved following energy delivery to the 
left atrial-pulmonary vein (LA-PV) junction or antrum
108, 109
 does not always translate into 
long term clinical success with only 50-60% of patients being cured following a single 
procedure 
110, 127
. The formation of durable transmural scar is critical to block electrical 
conduction between the LA and PV’s and prevent spontaneous pulmonary vein ectopics from 
triggering AF.   
Recent studies suggest that radiofrequency (RF) lesions within the left atrium can be 
visualised using delayed enhancement cardiac MR imaging
93, 98, 112, 115, 118, 119, 121
 . A good 
correlation between greater amounts of delayed enhancement quantified following ablation 
and a successful clinical outcome has been demonstrated 
93
. We have previously shown that 
acute cardiac injury following RF ablation comprises tissue necrosis (irreversible injury), 
inflammation (comprising both irreversible and reversible injury) and tissue oedema 
(reversible injury) 
115
. Whilst T2-weighted imaging enables oedema visualisation, DE 
imaging in the acute setting is likely to represent both necrotic and inflamed tissue 
114, 128
. In 
the chronic scans, it is likely that some of the areas of inflamed tissue recovers and other parts 
progress on to form scar and DE here is likely to represent true scar. The more complete the 
circle of tissue necrosis around the pulmonary vein, the less likely that LA to PV conduction 
will be restored. 
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It has been shown that RF lesion depth and dimensions are heavily influenced by catheter tip 
force 
129
. The Hansen Robotic System (HRS) has an incorporated pressure sensing 
mechanism (IntelliSense, MV, CA) to determine the force exerted by the catheter tip upon the 
myocardium. This facility and the ability to maintain a stable catheter tip position should 
improve the delivery of RF energy and enhance the occurrence of a tissue necrotic lesion, in 
comparison with a manually applied lesion 
130
.  
The present study examines the cardiac MR findings around the PVs following robotically 
guided ablation in comparison to manual lesion delivery and correlate this to the respective 
clinical outcomes. 
5.2  Methods 
5.2.1 Patient population  
Forty patients (28 male, mean age 54±13.8 years) with symptomatic, drug refractory 
paroxysmal AF undergoing their first PVI completed the study. 45 patients were consented 
for the study but five were excluded (3 because of claustrophobia with failure to complete the 
scan and 2 due to an ineffective respiratory navigator). All scans used for the purposes of data 
analysis were deemed of adequate quality for analysis by an experienced CMR operator. 
Therapeutic anti-coagulation with an INR >2 for at least 4 weeks prior to the procedure was 
mandated. The study was approved by the Local Research Ethics Committee. 
Acute procedural success was defined as PVI confirmed using a circumferential mapping 
catheter. Clinical outcomes are reported at 6 months follow-up. Patients were followed in 
clinic to assess symptoms. 24 hour Holter monitors were performed at 6 months. Recurrences 
were defined on the basis of 1) symptoms with ECG evidence of the presence of atrial 
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fibrillation/flutter/tachycardia or 2) the presence of symptomatic or asymptomatic episodes of 
atrial arrhythmia lasting for >30 seconds on ambulatory cardiac monitoring. 
 
 
Figure ‎5-1: The above flow diagram describes this single centre study  performed over 18 months. Of the 
45 patients consented, 3 developed claustrophobia during CMR image acquisition and 2 had suboptimal 
images due to navigator inefficiency. The remaining 40 patient studied underwent the same catheter 
ablation strategy for paroxysmal atrial fibrillation and were imaged between 3-4 months post procedure. 
Both selected single inversion recovery, SSIR and non-selective dual inversion recovery, NSDIR 
sequences were performed following gadolinium contrast administration. The routine imaging time point 
for SSIR following a look-locker scan was performed at 25 minutes post contrast injection whilst NSDIR 
was performed at two earlier time points (15 and 20mins) and at one later time point (30mins) post 
contrast delivery. Of the 15 patients studied, 12 patients had 24 good images that were analysed. 
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5.2.2 MR Image acquisition 
The CMR imaging technique utilised has been described previously in Chapter 4. In 
summary, T2-weighted images were acquired using a multi-slice Turbo Spin Echo (TSE) 
acquisition technique with a double inversion recovery (DIR) pre-pulse for black-blood 
imaging. Spatial pre-saturation with inversion recovery (SPIR) fat suppression was applied. 
The echo time used was set at 120ms with a linear profile ordering.  This enabled the image 
resolution to be set at 1.5x1.5mm
2
 with a slice thickness of 5mm. The number of slices was 
set to provide complete coverage of the left atrium (20-25 slices). Diaphragmatic motion was 
tracked and respiratory motion correction applied to minimize motion blurring and 
differences in respiratory phase between slices during image acquisition. 
In order to visualize DE, a 3D ECG-triggered, free-breathing inversion recovery (IR) turbo 
field echo (TFE) scan with respiratory navigator motion correction was performed with a 
pixel resolution of 1.3x1.3x4mm
3
, which was then reconstructed to 1.3x1.3x2mm
3
. Data were 
acquired at mid-diastole with a 150ms acquisition window and a low-high k-space ordering 
as well as SPIR fat suppression. The IR delay time was determined from a Look-Locker 
sequence and was set at a TI intermediate between the optimal TIs to null myocardium and 
blood. Previous work has validated this method for reproducible visualization of the late 
enhancement signal from necrotic tissue.
115
 DE scans were performed 20 minutes following 
contrast agent administration. The number of slices was set for complete atrial coverage (30-
40 slices). To optimize visualization of the PVs, slice orientation was performed in the four-
chamber view. Images obtained with this method appear to reflect the pulmonary veins at 
their maximal size. Similar MR sequences were used for images acquired (i) prior to ablation, 
(ii) within 24 hours of ablation and (3) 3-6 months following ablation. 
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5.2.3 Robotic Navigation System  
The RNS (Sensei Robotic Catheter System, Hansen Medical, Inc, Mountain View, 
California) is an electromechanical system comprising a physician workstation with 3 
components – instinctive motion controller, remote robotic catheter manipulation (RCM) arm 
and the artisan sheath (Figure 5.2). The latter sheath consists of an outer (14F) and an inner 
sheath (10.5F) which allows for the incorporation of any 7-French mapping or ablation 
catheter. Catheter navigation is performed by four pull wires in the internal sheath facilitating 
catheter insertion/de-insertion or deflection with an angle up to 360
o
, and two further pull 
wires in the external sheath allowing for insertion/de-insertion rotation or deflection. The 
steerable sheath system is connected to the RCM that is attached to the X-ray procedure table. 
RCM navigation is realised by the instinctive motion controller (Figure 5.2) which is 
integrated within the physician workstation, placed remotely from the patient table. The 
operator moves a ball in the workstation and this movement is transmitted to the steerable 
Artisan sheath system. In the absence of tactile feedback for the operator, a special feature 
that indirectly estimates catheter contact force on the tissue (IntelliSense) is present to ensure 









controller (top left and middle), the remote robotic catheter manipulator RCM (top right), the Artisan 
steerable sheath (bottom left) and the artisan sheath delivered through a short 14.5F sheath. 
 
5.2.4 Ablation Procedure 
A 6F decapolar catheter was placed in the coronary sinus to provide a reference for 
electroanatomic mapping and to enable LA pacing. Double transseptal puncture from the 
right femoral vein was performed manually and access to the left atrium was obtained using 
8.5Fr non-deflectable long sheaths, (St. Jude Medical Inc., St. Paul, MN, USA). Following 
the first transseptal puncture, intravenous heparin was administered to achieve an activated 
clotting time of between 300 and 400 seconds. Both circular mapping catheter 
(Inquiry™Optima™, St. Jude Medical Inc.) and  NaviStar® ThermoCool® 3.5 mm irrigated 
tip catheter (Biosense Webster Inc., Diamond Bar, CA, USA) were employed to create a 3-
dimensional geometry of the left atrium with either NavX™ (St. Jude Medical Inc., St. Paul, 
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MN, USA) or CARTO XP (Biosense Webster Inc., Diamond Bar, CA, USA).  Following 
this, the ablation catheter was withdrawn from the left atrium and inserted into the flushed 
Artisan sheath and subsequently connected to continuous irrigation. The Artisan RNS was 
placed within the right atrium via a short 14-Fr sheath in the right femoral vein and then  
manually introduced into the left atrium through the previous transeptal puncture. By leaving 
the ablation catheter out beyond the Artisan sheath, the ablation catheter functioned as a 
landmark under fluoroscopic guidance during the advancement of the Artisan sheath through 
the venous system and across over into the left atium. The Artisan tip was aligned with the 
fluoroscopy system and baseline force sensing pressure (Intellisense) was calibrated whilst 
the catheter was positioned in the middle of the left atrium with minimal electrical signal 
spikes being recorded on the ablation catheter. 
The circular mapping catheter was then placed in each pulmonary vein in turn while the 
corresponding LA-PV antrum was targeted with wide area circumferential ablation. The 
ablation catheter irrigation flow was set at 15 ml/min, power limited to 25 W on the anterior 
wall and 20 W on the posterior wall and temperature 40
0
C. Ablation lesions were marked on 
the LA geometry when there had been an 80 % reduction in the local electrogram voltage or 
after 30 seconds of energy delivery. One tag was applied to the shell per 30s RF energy 
delivery and a standard tag size was used throughout the study. If LA-PV conduction 
persisted despite wide area circumferential ablation, additional lesions were delivered at sites 
of earliest activation on the circular mapping catheter until entry block in all 4 veins was 
confirmed by observing the elimination or dissociation of pulmonary vein potentials. Exit 
block was not routinely assessed. Neither adenosine nor isoprenaline was routinely 
administered to test the integrity of PVI or to search for non-PV triggers of AF 
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The technical aspects of the ablation were identical in both robotic and standard approach 
apart from the different navigational approach and ablation  settings - flow limited to 17 




5.2.5 Image processing and analysis  
T2 and DE signal circumferential quantification was performed by reconstructing all CMR 
scans into individual left atrial shells using a semi-automated 3-D visualization method  
previously described in chapter 3 
115
. Areas of DE or high T2 signal intensity were defined as 
being more than three standard deviations above the mean signal intensity of an area of 
healthy ventricular myocardium. This threshold was chosen based on work assessing cardiac 
injury following ablation or myocardial infarction
90, 113
. The LA surface was colour coded 
according to the MIP values, ranging from green (minimum) to red (maximum). 
For the acute post ablation scan and chronic follow up scan, PVs were analyzed as ipsilateral 
pairs for each of the 40 patients, permitting analysis of 240 PV pairs (80 pre ablation pairs, 80 
acute scan pairs and 80 chronic follow-up scan pairs). For each PV pair, T2 and DE was 
quantified as occupying a percentage of the antral circumference. The % delayed gadolinium 
enhancement (DE), high T2-weighted signal (T2) and combination of delayed gadolinium 
enhancement and T2 (DE+T2) encircling the pulmonary veins was quantified. All 3D MR 
reconstructions were analyzed twice independently by two experienced readers, blinded to 
clinical outcome and to the timing of the scan following catheter ablation.  A high degree of 
interobserver agreement was seen on a Bland Altman test with a maximum observed 
difference of 10% seen. The mean±SD inter-observer error for DE, T2 and DE&T2 was 
1.5±2.5%, 1.5±3.5% and 0.8±2.2% which was acceptable for the purposes of data analysis. 
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5.2.6 Statistical analysis 
Summaries for continuous variables are expressed as mean ± confidence interval. Follow-up 
times are reported as the median and interquartile range (IQR).Categorical variables were 
compared among recurrences and non-recurrences groups using a chi-square test. The % 
circumferential encirclement by DE, T2 and DE&T2 groups were compared to test for 
differences between group means. Statistical analyses were performed using Stata (StataCorp 
2009). A linear regression model with predictor (code 1 for no recurrence and 0 for 
recurrence) and outcome T2, DE, T2&DE, DE/(T2&DE) respectively was applied and run in 
Stata. We used the vce (cluster subject) option in Stata
116
  to allow for inter-subject 
dependence (left and right pulmonary vein measurements from the same patient). Analyses 
for acute and chronic pulmonary vein findings on cardiac MR were performed separately. A 
p value of less than 0.05 was considered statistically significant. 
5.3  Results 
5.3.1 Patient and procedural data 
Table 5.1 outlines the clinical characteristics of the study population in both groups. 
Successful pulmonary vein isolation was achieved in all patients. Means for RF application, 
energy delivered and fluoroscopic time in the robotic group were 141±34, 88390J±38583J 
and 43±11.5min in comparison to 126±79 (p=0.52), 80011J±42757J (p=0.50) and 
55±18.5min (p=0.04) in the standard group. At 6 month follow-up, 12 (60%) in the robotic 
group versus 11 (55%) in the standard group  were arrhythmia free. Median time to 
recurrence was 78days (range 32 to 146 days) for the robotic group versus 96 days (range 68 
to 167days).Patients with recurrences in both groups were listed for a re-do ablation. In the 
arrhythmia free. In the standard group, 2 patients declined a further ablation, 2 pending and of 
the 5 patients (PAF) undergoing a second procedure, only 1 has remained arrhythmia free. 
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Overall success in the robotic group was 75% following 1.2 procedures compared to 60% 
following 1.25 procedures. Procedural complications include two femoral venous haematoma 
which resolved on its own and 1 pseudoaneurysm that did not require surgical intervention. 
No stroke, tamponade or oesophageal fistula occurred in this study and no pulmonary vein 
stenosis was detected on follow up MRI.  
 Table ‎5-1: Baseline Characteristics 







Male, n (%) 28 (70) 15 (75) 13  (65) 0.53 
Age (years) 54+-13.8 54+-14.3 55+-11.2 0.86 
AFduration (months) 30+-11.2 32+-9.1 30+-12.6 0.78 
LA size, cm           3.4+-3.5 3.4+-0.3 3.5+-0.2 0.92 
LVEF, %                     56±8 58±6 56±8 0.86 
Hypertension 11 7 4 >0.10 
Diabetes 1 0 1 >0.10 
Coronary Artery Disease 1 1 0 >0.10 
Thyroid 2 2 0 >0.10 
Smoking 6 4 2 >0.10 
Fluoroscopy time  (minutes) 48.9+-14.1 43.1+-8.6 54.8+-16.4 0.04 
Procedure time (hours) 210+-26.1 220+-21.4 199+-27.7 0.06 
Number of applications 134+-42 141+-33 126+-58 0.63 
Energy delivered (Joules) 84201+-28855 88391+-28519 80011+-28338 0.46 
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5.3.2 Cardiac MR evaluation 
Baseline circumferential burden of DE and T2 weighted signal prior to any ablation were 
similar in both groups (Figure 5.3) and did not occupy more than 5% of the PV 
circumference. Post-ablation acute imaging was performed between 18 and 24 hours 
following catheter ablation. Figure 5.3 demonstrates the typical T2-weighted (figure 5.3 a) 
and DE (figure 5.3 b) appearances in two patients before and after catheter ablation. The left 
atrial burden of DE and T2-weighted signal was significantly increased following both 
catheter ablation approaches in comparison with pre-ablation (Figure 5.3). In general, DE 
signal was concentrated in the PV antral region while T2 signal was more widely distributed 
in the atrium, remote from sites of ablation. 
Combined analysis of DE and T2 signal, using reconstructed shells co-displaying both signal 
types, revealed areas of T2 enhancement to overlap and interdigitate with those areas of high 
DE signal intensity (figure 5.3). Hence the total combined DE and T2 percentage PV 















Figure ‎5-3 : (a) Serial T2  CMR scans performed on a single patient following robotic and standard navigated catheter ablation at 3 time points.(b) Serial  DE CMR 
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(a)                                                                                                                               (b) 
Figure ‎5-4 : Depicts an example of a series of 3-D LA reconstructed shells (at 3 time points) in two patients to compare robotic (3a) versus standard catheter 
ablation‎(3b).‎Blue‎represents‎areas‎of‎T2‎signal‎whilst‎red‎represents‎DE.‎Greater‎‘islands’‎of‎red‎is‎seen‎in‎the‎robotic‎assisted LA shell. 
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In the robotic group, the LPV circumferential extent of DE signal alone, T2 signal alone and 
the combination of both signal types was 72±13%, 80±19% and 94±10% respectively. For 
the RPVs, the circumferential extent of DE signal alone, T2 signal alone and the combination 
of both signal types was 71±13%, 78±30% and 95±10%respectively. Compared to DE alone, 
the combined DE and T2 signal was significantly greater for both left (p<0.0001) and right 
(p<0.0001) PVs. Complete antral encirclement with combined DE and T2-weighted signal 
was seen in 14/30 (47%) PV pairs at the acute scan.  
In the standard group, the LPV circumferential extent by DE signal alone, T2 signal alone 
and the combination of both signal types was 60±18%, 71±35% and 87±11%respectively. 
For the RPVs, the circumferential extent of DE signal alone, T2 signal alone and the 
combination of both signal types was 58±23%, 81±15% and 89±13%respectively. Compared 
to DE alone, the combined DE and T2 signal was significantly greater for both left 
(p<0.0001) and right (p<0.0001) PVs. In contrast to the robotic group, complete antral 
encirclement with combined DE and T2-weighted signal was seen in half of the PV pairs at 
the acute scan, 7/30 (23%). 
 Follow-up CMR scans were performed between 3 and 6 months post procedure. 
Here, T2 signal had largely resolved (Figure 5.4), while a decline in the extent of DE signal 
was seen in both groups. In the robotic group, the circumferential extent of DE signal in the 
LPV decreased from 72±13% to 58±22% (p=0.002); for the RPVs, the circumferential extent 
of DE decreased from 71±13% to 53±22% (p=0.001). In the standard group, the 
circumferential extent of DE signal in the LPV decreased from 60±18% to 47±32% (p=0.09); 
for the RPVs, the circumferential extent of DE decreased from 58±23% to 44±30% (p=0.09). 
Discontinuities in areas of DE signal could be seen in both groups.  Overall, a higher mean 
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percentage encirclement was consistently observed in the robotic group in both acute and late 
scans with a 10% higher margin encirclement observed on the chronic scans by DE. 
 
Figure ‎5-5: This scatter-boxplot shows a comparison of pre, acute and late T2, DE and combined T2&DE 
for both robotic and standard ablation. Each individual scatter plot represents the raw data for that 
specific group. The dots within each group have been dispersed horizontally to optimise visualisation and 
clarity. The boxplots on the other hand represent median (red line), 95% confidence intervals (yellow 
box) and 1 standard deviation (blue box). An overall higher enhancement is seen post procedure in the 
robotic group compared to the standard group 
 
5.3.3 Outcome in relation to CMR assessment 
In both robotic and standard groups, acute and late scan data were analysed into two groups 
according to the respective clinical outcome – those with and without AF recurrences. 160 
pairs of PVs (80 robotic, 80 standard) analysed previously were divided according to the 
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presence or absence of arrhythmia recurrences. Figure 5.5 summarises the percentage 
circumferential encirclement of DE, T2-weighted signal and the combination of DE &T2 
around the left and right PV pairs by clinical outcome for both the acute and late scans. 
In the robotic group, the acute CMR findings in the arrhythmia free versus recurrences by DE 
alone, T2 alone and a combination of DE&T2 was 74±13%, 76±16% and 93±13% versus 
68±14%, 82±16% and 96±5%. Similarly, in the standard group, the percentage encirclement 
by DE alone, T2 alone and a combination of the two in the arrhythmia free versus recurrences 
group was 70±25%, 71±33% and 90±13% versus 46±19%, 81±24% and 87±14%. 
recurrences, DE was higher in the robotic group ( 43±19% vs 30±35%, p=0.02). A 
comparison of energy delivered, DE quantified on late CMR scans and clinical outcome 
between the two groups is presented in Figure 5.6. In contrast to the standard group, the 
points on the robotic scatter plot are less spread and more close together with DE values 
being above 40%. Furthermore, at energy values ranging between 40000J - 90000J, greater 
numbers of points are observed with higher DE in the RNS group. 
On the late scans, DE was the predominant signal type seen and was significantly greater in 
both  groups for arrhythmia free versus recurrences  (robotic 64±18% versus 43±19% and 
standard 60±14% vs 30±35%  respectively, p <0.0001). Arrhythmia free patients had an 








Figure ‎5-6: This scatter plot describes the relationship between energy delivered and scar created as 
quantified on DE-CMR by  percentage PV encirclement. Both robotic and standard ablation datasets 
have been categorised into no recurrences versus recurrences. The blue circles representing robotic 
procedures appear less dispersed and have a minimum DE value of around 40%. The red circles 
representing standard catheter ablation are widely dispersed and have a minimum DE value of 15% to 
30% despite high total energy delivery. This suggests better catheter-tissue contact conferred by the 
robotic system yielding higher percentages of  PV antrum scar. 
 
5.4 Discussion 
This is the first report to compare robotic and standard catheter ablation lesions using cardiac 
MR and correlate the findings to clinical outcome. The main findings of this single-centre 
study are as follows – (1) electromechanic robotic assisted lesion delivery results in greater 
percentages of PV encirclement quantified on CMR, (2) CMR atrial shell analysis of the 
lesion patterns reveal a  more contiguous encirclement around the PV in the robotically 
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navigated  RF ablation group in comparison to a scattered pattern observed in the standard 
group, (3) a significantly less regression in acute versus late scan DE  in the robotic 
recurrences group suggest that energy delivery with this approach favourably results in more 
longer term robust  lesions, (4) the more closely placed points observed on the robotic scatter 
plot suggests better consistency and higher reproducibility in lesion delivery with an overall 
greater minimum scar formation (DE > 40%).    
The challenges during AF ablation arise from not only the importance of precision in catheter 
movement, catheter stability and tissue contact 
129, 131
 but also the variable heterogeneity in 
PV anatomy, chamber size, tissue thickness 
132
. Several studies have previously reported that 
robotically navigated catheter ablation can be performed effectively in achieving acute 
electrical isolation of PV potentials and mid-term freedom from arrhythmia with 
complication rates comparable to conventional procedures (Table 5.2).  This study extends 
the clinical experience on both feasibility and safety of the robotic navigation catheter 
ablation and also reports on the clinical outcome.  Former studies have showed that robotic 
navigated catheter ablation can be performed safely with a marked reduction in fluoroscopic 
time and achieve a high acute success rate. Recently, mid-term success rates described in 
Hlivak’s study demonstrates a 63% first procedure success rate and a 86% success rate 
following 1.21 procedures per patient at 15 months follow-up 
133. Natale’s group in the 
largest single centre RNS study achieved an overall 85% success rate at 14.1±1.3months 
132
. 
Both the introduction of the Intellisense contact force evaluation and RNS procedural 
experience over the last 5 years recommending cautious power settings especially during LA 
posterior wall ablation have reduced the overall complication profile. The recent study 
involving 100 RNS procedures reported only 2 small haematomas at the puncture site, a 





Chapter Five-Technology Assessment of Atrial Fibrillation Catheter Ablation by Cardiac Magnetic 
Resonance Imaging 
 



















1 Saliba W, 
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Atrial fibrillation 
ablation using a robotic 
catheter remote control 
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hours 
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hours 
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5 Wazni O, 
Natale A, 
Saliba W et al 
2009 
Experience with the 
Hansen Robotic System 
for Atrial Fibrillation 
Ablation—Lessons 
Learned and Techniques 
Modified: Hansen in the 
Real World 
 
64 3.1± 0.8 
hours 
24±10mins 81% at 12 
months 
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Paroxysmal Atrial 
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hours 
11.9 ± 7.8 
mins 
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In the context of cardiac MR assessment of catheter ablation lesions, delayed enhancement 
MRI (DE-MRI) following the administration of gadolinium-containing contrast agents has 
been used to visualize the atrial tissue injury following catheter ablation 
93, 98, 112, 115, 118, 119, 121, 
113 
 




. The poor washout kinetics of gadolinium in areas of damaged cells results in contrast 
agent accumulation, thus highlighting areas of tissue injury. In viable myocardial tissue, 
gadolinium washes out faster resulting in reduced areas of enhancement 
134-136
. A good 
correlation between greater amounts of DE on late scan imaging and  better procedural 
outcome has been documented 
93
. On the other hand, T2 weighted magnetic resonance 
imaging has been used to visualize myocardial oedema following radiofrequency ablation. 
Left atrial oedema is thought to be common following AF ablation. Okada et al  used electron 
beam tomography to show that an increase in LA wall thickness occurred immediately 
following AF ablation and resolved within one month 
137
.  This increase in wall thickness was 
attributed to atrial wall oedema. Recently, Marrouche et al  using CMR demonstrated the 
presence of T2 enhancement alongside DE in patients following catheter ablation. A 
correlation between low voltage areas (<0.05mV mapped on Carto) and areas of T2 
enhancement was shown here. A comparison between acute and 3 month CMR scans 
performed by this group showed loss of T2 enhancement areas suggesting resolution of 
oedema. 
This study reports the cardiac MR findings comparing robotic navigated catheter ablation 
lesions to standard catheter ablation. The higher mean percentage encirclement consistently 
observed in the robotic group in both acute and late scans is likely a function of both catheter 
stability and tactile feedback with Intellisense conferring better catheter control. Improved 
lesion delivery resulted in an overall 10% higher margin encirclement observed on the RNS 
late scans. Whilst almost similar % encirclements were observed on late scan DE between the 
two groups with no recurrences, a significantly higher amount of DE was noted in the robotic 
group. This lower regression of DE between the acute and late scans in the robotic 
recurrences group suggests an overall better quality lesion created using the RNS. Anova 
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comparisons between the two groups demonstrate a narrower range in % encirclements in the 
robotic group confirming less variability in lesion delivery, suggesting better tissue contact. 
The overall more contiguous lesion set appearance on qualitative examination of the 3-D 
CMR atrial shells in the robotic group is again attributable to better catheter control and 
greater stability.  More circular shaped encirclement patterns observed in the RNS group 
suggests that the system allows for a more accurate and precise catheter movement along the 
PV antrum with sufficient tissue contact creating better adjoining lesions. The association 
between energy delivered and scar formation analysed on late DE CMR scans was examined. 
At a set range of energy delivery, more points with higher DE was observed on the robotic 
scatter plot. This is likely to be a function of  better catheter stability conferred by the RNS. 
The better consistency and higher reproducibility inferred from both the smaller standard 
deviation and more closely placed points on the scatter plot  implies a relatively a higher 
precision in lesion delivery in the robotic group  in comparison to the standard.  
5.4.1 Potential Clinical Significance 
On average, patients with atrial fibrillation undergo between 2 to 3 ablation procedures to 
become arrhythmia free. Repeat procedures incur cost, utilizing further health resources and 
more importantly inconveniencing  the patient by subjecting them to another ablation.  The 
creation of more durable ablation lesions will benefit the patient greatly alongside optimising 
and saving on healthcare resources which is becoming a necessity, more so in the present 
economic climate. 
RNS confers greater catheter stability, better control and improved tissue contact allowing for 
the creation of more durable contiguous lesions around the PV antrum. The reduced  DE 
variance  and overall higher percentage encirclement  observed on CMR quantification in the 
robotic recurrence group suggests both a higher consistency in lesion delivery and greater 
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atrial tissue injury. This is evidenced by the overall 75% success rate following 1.2 
procedures in comparison to a 60% success following 1.40 procedures in the standard group. 
The recurrence arrhythmia pattern of atrial tachycardia which was greater in numbers in the 
RNS group suggests that the index ablation had successfully modified the arrhythmia into a 
more organised rhythm which was successfully ablated during the subsequent procedure.  
5.4.2 Study limitations 
This is a small, hypothesis-generating study and the role of Robotic Navigation Syetem 
assisted catheter ablation in conferring overall better mid to long-term clinical outcome 
would require a larger study for validation. With regards to cardiac MR tissue injury 
quantification, there are some limitations with no widely accepted standardisation of 
technique between laboratories.  
Whilst there is evidence from animal studies that gadolinium is predominantly a marker for 
tissue necrosis, by virtue of its kinetics, it also accumulates in extracellular water which is 
also seen in acute inflammation. In addition, while T2 MRI can preferentially represent 
myocardial oedema, there is currently no robust histological evidence corroborating this in 
the atria following radiofrequency ablation. 
Detection of asymptomatic recurrences of AF without the use of continuous monitoring is 
impossible. Because of the frequency of monitoring, it is likely that the incidence of 
asymptomatic AF is underreported in the current study. 
5.5 Conclusion 
The cardiac MR examination findings in this study suggest that remote robotic assisted 
navigation systems permit the creation of more contiguous, durable scar around the PV 
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antrum. This is likely to be a function of increased catheter stability improving tissue contact 
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6 Novel Dual Inversion Recovery Pre-Pulse for Improved  Blood 
Suppression to Better Visualise Scar 
6.1 Introduction 
Pulmonary vein disconnection following atrial tissue necrosis is the principal mechanism by 
which patients with paroxysmal atrial fibrillation benefit from catheter ablation therapies. To 
assess the efficacy of catheter ablation, it is useful to determine and quantify areas of atrial 
injury created by measuring the final scar size. The recent few years have seen the use of 
delayed enhancement cardiac magnetic resonance imaging, DE-CMR in visualising areas 
within the left atrium following catheter ablation 
90, 93, 98, 112, 115, 118, 119, 121, 124, 126, 138
. Studies 
have confirmed that the higher the degree of atrial scar created, the better the clinical 
outcome
93, 98
. Furthermore, DE-CMR imaging has been used to guide re-do procedures by 
identifying gaps between lesion sets and thus providing a potential road map to guide target 
areas of ablation 
98
. 
However the present method of atrial scar visualisation and quantification is affected by the 
presence of some contrast remaining within the atrial blood pool. The presence of this 
increased signal intensity can lead to an overestimation of scar presence during 
quantification. Furthermore, the difference in circulating atrial blood pool contrast between 
individuals may affect quantification analysis in a cohort study. In addition, imaging has to be 
performed following the washout of gadolinium contrast from the blood pool which can be 
up to 30 minutes following contrast injection. 
Recently, the dual-IR pre-pulse technique was shown to achieve improved blood suppression 
in delayed enhancement images of ventricular scar 
139
. In this study, we aimed to examine the 
application of this sequence in imaging atrial scar following radiofrequency catheter ablation 
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6.2  Methods 
6.2.1  Study population  
This prospective study was conducted between July 2011 and December 2011 at a single 
tertiary centre. Figure 6.1 outlines the study design. Patients with paroxysmal atrial 
fibrillation undergoing follow-up CMR scans, median 5months (IQR 4-7months) post 
catheter ablation  
 
Figure ‎6-1: This flow diagram describes this single centre study design performed over 6 months. All 
patients recruited underwent the same catheter ablation strategy for paroxysmal atrial fibrillation and 
were imaged between 3-4 months post procedure. Both selected single inversion recovery, SSIR and non-
selective dual inversion recovery, NSDIR sequences were performed following gadolinium contrast 
administration. The routine imaging time point for SSIR following a look-locker scan was performed at 
25 minutes post contrast injection whilst NSDIR was performed at two earlier time points (15 and 
20mins) and at one later time point (30mins) post contrast delivery. Of the 15 patients studied, 12 patients 
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were recruited. To ensure that the CMR findings reflected atrial scar following the index 
catheter ablation, patients were not enrolled if they had a previous left atrial ablation. Further 
exclusion criteria included contraindications to DE-CMR (i.e metallic intracranial implants, 
poor renal function, pacemakers) and general anxiety/claustrophobia. Therapeutic anti-
coagulation with an INR >2 for at least 4 weeks prior to the procedure was mandated. All 
patients provided written informed consent to participation in the study which was part of a 
larger CMR study aimed at quantifying areas of delayed enhancement within the left atrium 
following catheter ablation and corroborating this to clinical outcome. The study was 
approved by the Local Research Ethics Committee. 
6.2.2  Catheter Ablation 
This has been previously described in chapter 4. In summary, two transseptal punctures were 
made and access to the left atrium was obtained using 8.5Fr non-deflectable long sheaths, (St. 
Jude Medical Inc., St. Paul, MN, USA). A 3-dimensional geometry of the left atrium was 
created using either NavX™ (St. Jude Medical Inc., St. Paul, MN, USA) or CARTO XP 
(Biosense Webster Inc., Diamond Bar, CA, USA). A circular mapping catheter 
(Inquiry™Optima™, St. Jude Medical Inc.) was then placed in each pulmonary vein in turn 
while the corresponding LA-PV antrum was targeted with wide area circumferential ablation. 
Energy was delivered through a NaviStar® ThermoCool® 3.5 mm irrigated tip catheter 
(Biosense Webster Inc., Diamond Bar, CA, USA) with flow limited to 17 ml/min, power 




6.2.3 CMR   
Areas of post ablation left atrial scar was imaged using a 1.5 Tesla Philips Achieva MR 
system (Philips Healthcare, Best, Netherlands) with  a 32 channel surface coil (Invivo, 
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Orlando, Florida, USA).  The standard CMR imaging technique utilised has been described 
previously in Chapter 4. In summary, the  conventional LGE imaging was performed using a 
3D free breathing, respiratory-navigated, ECG-triggered gradient echo (GE) sequence (2).  
Image acquisition was timed at end diastole using a preceding b-SSFP cine image. Imaging 
parameters included: TE/TR=2.6/5.4ms, TR effective=1 heartbeat, navigator window=5-





navigator restore was removed and a delay of 100ms was applied between the navigator and 
image acquisition to avoid the pulmonary vein inflow artifact (x4). The traditional IR-GE 
pre-pulse (Figure 6.2a) was employed with the TI set to null normal myocardium using a 
preceding Look Locker scan. Previous work has validated this method for reproducible 
visualization of the late enhancement signal from necrotic tissue 
115
. The dual-IR-GE 
sequence (Figure 6.2b) employed two non-selective inversion pre-pulses separated by  time 
delays TI1 and TI2. These delays were optimized to achieve signal suppression in a T1 range 
250 - 1400ms. The aim of the dual IR sequence is to simultaneously suppress both normal 
atrial wall and blood signal whilst maintaining high signal in atrial scar. 
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Figure ‎6-2: Inversion recovery and (b) Dual inversion recovery pre-pulses with corresponding signal 
versus T1 plots.  The IR pre-pulse only suppresses the T1 of normal atrial wall whereas both the atrial 
wall and blood are suppressed with the dual-IR pulse. 
6.2.4 Image Analysis  
6.2.4.1 CNR and SNR Image analysis.  
 Regions of interest were manually defined in 5 slices in the blood pool and in right superior 
pulmonary vein scar. Blood and scar signal-to-noise (SNR) and scar-to-blood contrast-to-
noise (CNR) values were measured in all images using Osirix medical imaging software.   
6.2.4.2 Qualitative Visual Image analysis   
Images were assessed and scored by 5 experienced CMR readers. Five categories were 
assessed - atrial blood pool nulling, scar visualization, noise, artefact, and blur with a score of 
0-4 conferred. Individual categories were scored as following. For blood pool nulling, 0= no 
nulling, 1=inadequate nulling, 2=adequate nulling, 3 good nulling and 4 very good nulling.  
For scar visualization, 0= no scar seen, 1= scar visible with poor demarcation of borders or 
edges, 2=scar visible with moderately blurred borders or edges, 3= scar visible with mildly 
blurred borders or edges and 4= scar visible with sharply demarcated borders or edges. Signal 
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noise, artifact and noise respectively graded as 1= great amount, 2=moderate amount, 3= 
mild amount and 4= none. Observers were blinded to the type of sequence used. 
6.2.4.3 Quantitative Delayed Enhancement analysis   
Areas of delayed enhancement around the pulmonary veins were manually segmented out by 
two experienced CMR readers that were blinded to both clinical outcome and acquisition 
sequence used.  Quantification was performed in Osirix.  
6.2.4.4 Statistical Analysis 
Summaries for continuous variables are expressed as mean ± confidence interval. Follow-up 
times are reported as the median and interquartile range (IQR).Categorical variables were 
compared among recurrences and non-recurrences groups using a chi-square test. 
6.3 Results 
Of the 50 patients participating in the initial CMR study, 15 patients were enrolled into this 
study where 12 good quality scans were acquired.  Two scans were suboptimal due to 
navigator inefficiency and 1 scan had to be stopped as the patient became claustrophobic. 
6.3.1  Patient characteristics  
Demographics and clinical characteristics are shown in Table 6.1. The baseline 
characteristics include mean age 58 ± 10.7 years, 10 male patients (67%) with a mean LA 
size of 3.7±0.5, AF duration of 28±16 months and BMI of 23.2 ± 1.8.  Successful acute 
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Table ‎6-1:Patient demographics categorized into no recurrences and recurrences at 6month clinical follow up. 
 All       


































LA size, cm           3.7±0.5 3.5±0.2 3.7±0.3 0.14 
LVEF, %                     55±5 60 50 0.29 
Hypertension 5 2 3 >0.10 
Valve Disease 1 0 1 >0.10 
History of 
smoking 
1 1 0 >0.10 
Thyroid disease 1(4%) 0   1(9%) >0.10 
Previous ablation none None none N/S 
AF, atrial fibrillation; LA, left atrium; LVEF, left ventricular ejection fraction 
6.3.2 CMR 
Dual-IR images achieved superior blood suppression at an earlier time point (Figure 6.3). At 
15 minutes effective nulling of the atrial blood pool is achieved with the NSDIR sequence in 
comparison to 25-30 minutes in the SSIR sequence .  
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Figure ‎6-3: (a) Three patients undergoing both dual inversion recovery imaging (at 15mins, 20 mins and 
30 mins) and single inversion recovery (at 25 mins) following contrast administration are depicted here. 
(b) This series depicts the images acquired from a single patient undergoing single inversion recovery 
followed by dual inversion recovery 2 weeks later. Effective nulling of the atrial blood pool is achieved at 
an earlier time point, 15 minutes with the NSDIR method in comparison to 30 minutes in the SSIR 
sequence. 
 
Blood SNR values were significantly reduced at all time points compared to IR images 
(Figure 6.4a) whereas there was no significant difference in scar SNR (Figure 6.4b). Scar-to-
blood SNR values were significantly improved with dual-IR after 20 and 30 minutes 








Figure ‎6-4 : (a) Blood SNR, (b) scar SNR and (c) scar to blood CNR measurements for both selective 
single inversion recovery and non-selected dual inversion recovery images. The horizontal bars indicate 
statistical significance (<0.05) in a paired t-test 
6.3.3  Qualitative visual CMR assessment  
Table ‎6-2: Qualitative Visual Assessment of Left Atrial Gadolinium Enhanced Scans following Pulmonary 
Vein  Encirclement for Paroxysmal AF. 
 
 SIR DIR 
Blood Pool Nulling Score (range 2-3) 
Adequate to good nulling 
Score( range3-4) 
Good to very good nulling 
Scar Visualization Score (range 1-3) 
Scar visible, ranging from poor to mildly blurred border 
demarcation  
Score( range3-4) 
Scar visible, mildly blurred to sharp border demarcation  
Signal Noise Score( range3-4) 
Mild amount to no noise 
Score( range 1-3) 
Mild to moderate amount of noise 
Artifact Score( range3-4) 
Mild amount to none 
Score( range3-4) 
Mild amount to none 
Blurring Score( range3-4) 
Mild amount to none 
Score( range3-4) 








IR 25 mins Dual‐IR 15 mins Dual‐IR 20 mins Dual‐IR 30 mins 







IR 25 mins Dual‐IR 15 mins Dual‐IR 20 mins Dual‐IR 30 mins 
a) Blood SNR values  
           IR                  Dual-IR            Dual-IR          Dual-IR 
        25min           15min             20min            30min 
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6.3.4 DE quantification by hand-segmentation 
Quantification of scar was performed by manual segmentation of areas of atrial enhancement 
slice by slice in all patients. Figure 6.5 shows a scatter plot comparing quantified areas of SIR 





 respectively for standard inversion recovery versus dual inversion recovery. 
The linear regression in the scatter plot comparing SIR versus DIR yields a value of 0.69. A 
slope close to 1.0 would imply an almost similar range of values between the two groups. 
However a value of 0.69 implies that quantification performed on the DIR images  were  
lower in comparison to the SIR.  
 
Figure ‎6-5: A comparison between atrial enhancement regions quantified  in the non-selective  dual 
inversion recovery (NSDIR) images versus areas quantified in the selected single inversion recovery 
(SSIR) images in 12 patients is demonstrated in this scatter plot. The linear regression in the scatter plot 
yields a value of 0.69 implying that quantification performed on the DIR images  were  lower in 
comparison to the SIR images.  
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6.4 Discussion 
Main findings are 1) NSDIR achieves better atrial blood pool suppression conferring 
improved delayed enhancement visualisation 2) patient time within the scanner is reduced 3) 
improved visualisation enables more accurate and precise scar quantification. 
Targets for atrial substrate modification have evolved from ablating anywhere within the 
pulmonary vein to wide encircling lesions around the pulmonary vein antrum and additional 
RF energy applications targeting anatomic areas (left atrial roof line, mitral isthmus lines, 
right atrial structures) and electrophysiological parameters (complex fractionated atrial 
electrograms, CFAEs) 
77
. Nevertheless, single procedure success rates are modest, suggesting 
that the factors which contribute to acute electrical isolation are not well understood 
110
. This 
has subsequently led to a need for an effective tool in assessing catheter ablation lesions in 
patients. Understanding the nature of these radiofrequency lesions (full thickness versus 
partial thickness) assessing their distribution in relation to anatomic landmarks and 
following-up these lesions over time may help improve our knowledge in understanding the 
variation in catheter ablation outcome results and possible underlying mechanisms 
responsible for AF initiation and maintenance. Previously parameters affecting lesion 
creation have been assessed in animal models looking at temperatures achieved, power 
delivered, tissue contact force, catheter orientation, duration of energy delivery and blood 
flow within the cardiac chambers
140
. However, there are technical limitations in extrapolating 
this data directly into patients as catheter orientation, catheter stability, blood flow and exact 
tissue contact force achieved has been difficult to assess. 
The recent advancement
 
in novel cardiac magnetic resonance imaging sequences has allowed 
for the visualisation, quantification and characterisation of post-procedural radiofrequency 
lesions in vivo
90, 93, 98, 112, 115, 118, 119, 121, 124, 126
. This tool is rapidly proving to be an invaluable 
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commodity for researchers, electro physiologists and patients offering numerous benefits in 
improving the quality and standards of care delivery 
124
.  Table 6.3 summarises the present 
contemporary CMR studies evaluating post-ablation atrial scar. Improved visualisation of 
scar is important in correctly identifying areas that have been successfully ablated. More 
importantly, delayed enhancement atrial imaging has recently been utilised to guide repeat 
procedures and identify gaps between areas of previous ablation 
98
. 
This novel technique confers an overall better visualisation of left atrial delayed enhancement 
areas with improved atrial blood pool nulling and better definition of the edges and 
boundaries of DE areas.  Shoulders of the DE areas are better demarcated enabling areas of 
gaps to be better visualised. 
The linear regression of 0.69 in Figure 6.5 is likely to correlate with the improved atrial blood 
nulling achieved in the NS-DIR technique, thus reducing the likelihood of the quantification 
process incorporating  enhancement within the blood pool adjacent to the previously ablated 
tissue. 
6.4.1 Post Ablation Atrial Scar assessment by CMR 
Adequate catheter-tissue contact is integral in creating durable ablation lesions in order to 
maintain long term sinus rhythm 
141
. At present all available data during the development of 
catheter ablation technology stems from animal work 
140
. Clinical use and effectiveness is 
determined by follow-up outcomes. The utility of post ablation CMR of lesions allows for in 
vivo scar assessment of areas within the left atrium following energy delivery. This may help 
in both understanding mechanisms of  recurrences and improving present ablation techniques. 
Key catheter ablation research areas  including contact force, catheter stability, type of energy 
delivered and materials used in catheter design can be assessed in vivo. Furthermore, the 
effectiveness of electronic anatomical navigation systems in guiding catheter ablation through 
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the sometimes challenging heterogenous LA-PV junction anatomy can be evaluated by 
correlating ablation lesion points on the EAM shells to areas of delayed enhancement on the 
left atrial CMR shells
104
. 
6.4.2 Clinical implications 
This new technique enables an overall improvement in image quality with the added bonus of 
a shorter acquisition time. The latter is important in improving patient journey and experience 
within the MR scanner and optimising resources by reducing scan duration time whilst the 
former ensures quality control. It is important to note the standard inversion recovery method 
relies on a Look-Locker sequence to be performed and the time delay to be ascertained by the 
individual operator to ensure optimum nulling to visualise areas of delayed enhancement. 
NS-DIR on the other hand mitigates this step, by-passing the element of operator variability 
in choosing the trigger delay for nulling. In the setting of a research study, this becomes 
pertinent as the imaging technique is more reproducible.  
6.5  Study Limitations 
The study sample population utilised here is small.  Nevertheless the images acquired suggest 
good clinical potential and a larger study is currently being planned.  
6.6  Conclusion 
The application of dual-IR CMR sequence  achieves high quality  delayed enhancement 
images earlier following contrast administration.  There is a demonstrable  improvement in   
scar contour  visualization  and boundary definition achieved within a shorter time  span. 
 
 
Table ‎6-3: Summary of Left Atrial CMR studies following Catheter Ablation to-date 
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23 AF patients  
imaged pre and 
post-ablation 
1.5-T Achieva MR 
scanner (Philips 




were AF free at 149±72 
days follow-up 
A comparison of pre and 
post ablation DE CMR 
scans showed new 
regions of delayed 
enhancement (i.e scar) 
within the LA and ostia of 
the PVs in all patients 
following radiofrequency 
ablation.  




Hauser  , 
2008 
Left Atrial function 
and scar after 
catheter ablation 
of atrial fibrillation 
33 AF patients  
(24PAF,9nonPAF) 
imaged pre and 
post-ablation 
1.5-T Achieva MR 
scanner (Philips 
Healthcare Best, the 
Netherlands); 
0.2mmol/kg Magnevist; 
6 month outcome not 
stated. 
An association between 
decreased LA size and 
reduced atrial systolic 
function on CMR was 
observed following 
catheter ablation of AF. A 
strong linear correlation 
between the change in 
LA EF and scar volume 
was documented.   













35 AF patients  
(17PAF,18 
nonPAF) imaged 
30 to 60 days post 
ablation  
1.5-T Achieva MR 
scanner (Philips 
Healthcare Best, the 
Netherlands); 
0.2mmol/kg Magnevist; 
22/35 (63%) were AF 
free at 6.7±3.6 months. 
Post ablation 
quantification of extent 
of scar by DE CMR , 
especially RIPV 
enhancement predicted 
AF recurrences. Overall 
the LIPV displayed the 
most circumferential 
enhancement, followed 
by the RIPV, the LSPV and 

















Imaging in Patients 
With Atrial 
Fibrillation 
81 AF patients 
(40PAF,41 
nonPAF) imaged 
pre procedure and 
6 healthy 
volunteers 
1.5-T Avanto  MR scnner 
(Siemens Medical 
Solutions);0.1mmol/kg 
Multihance ; 56/81 
(69.1%) were AF free at 
9.6±3.7 months 
Pre-ablation DE CMR 
provides a non-invasive 
metric of overall disease 
progression (mild, 
moderate and extensive) 
and distribution of 
pathological regions 
(septum, anterior and 
posterior wall) within the 
LA.  Predictors of ablation 
success were dependent 
on the extent and 







Peters et al, 
Relationship 
between intended 
sites of RF ablation 
and post-
procedural scar in 
AF patients, using 
19 AF patients 
imaged at > 30  
days post ablation 
1.5-T Achieva MR 
scanner (Philips 
Healthcare Best, the 
Netherlands); 
0.2mmol/kg Magnevist; 
10/19 (53%) were AF 
Whilst both visual and 
quantitative correlation 
was observed between 
areas of enhancement on 
post ablation DE CMR 
and points marked on the 
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free at 4.9±2.8 months. Carto map, about 20% of  
the Carto ablation  sites 
did not have 
corresponding 
enhancement points on 
the DE scan and 5% of DE 
regions were without 








Evaluation of Left 
Atrial Lesions After 
Initial and Repeat 
Atrial Fibrillation 
Ablation 
144 AF patients 




1.5-T Avanto  MR scnner 
(Siemens Medical 
Solutions);0.1mmol/kg 
Multihance ; 102/144 
(71%) were AF free at 
10.2±5.1 months 
Using post ablation 
quantification of extent 
of scar by DE CMR, both 
the number of complete 
circumferential PV 
antrum lesions and the 





PV lesions were not 
always observed, 
achieving all four 
complete PV 
encirclement was 
infrequently seen; an 
important endpoint to 
maintaining durable 
pulmonary vein isolation.   
Identification of breaks in 
ablation lesions which 
correlate with electrical 
conduction on these 
scans can be used as 

















Fibrillation: A DE- 
MRI Guided 
Approach 
120 AF patients 
imaged at two 
time points: pre 
and >3 months 
post ablation; 
 
1.5-T Avanto  MR scnner 
(Siemens Medical 
Solutions);0.1mmol/kg 
Multihance ; 83/120 
(69%) were AF free at 
follow-up 
A corroboration between 
extent of pre-ablation 
staging of scar quantified 
on DE CMR scans (Utah 
stage 1 <5% DE, Utah 
stage 2, 5-20% DE Utah 
stage 3, 20-35% DE and 
Utah stage 4, >35% DE) 
and post ablation clinical 
outcome identified 2 
subgroups – 
excellent(minimal 
fibrosis) or poor 
(extensive fibrosis) 
prognosis following 






Evaluation of the 
left atrial substrate 
in patients with 
lone atrial 
fibrillation using 
333 AF patients 




1.5-T Avanto  MR scnner 
(Siemens Medical 
Solutions);0.1mmol/kg 
Multihance ; 27/40 
(68%) lone AF and 
Pre-ablation scar 
quantification as a 
measure of extent of LA 
structural remodeling on 
DE-CMRI did not differ 
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 170/293 (58%) non-lone 
AF patients were AF 
free at 10.8±7.8 months 
between patients with 







Using a LGE-MRI 
based Model: 
From the Clinic to 
the 
Electrophysiology 
387 AF patients 
(187PAF, 
200nonPAF) 
imaged pre and 
post procedure ; 
Either 1.5-T Avanto or 3-






postablation, T2 signal 
was seen not only in 
regions subject to RF 
energy but also distant 
regions whilst the >3 
month post ablation 
scans showed a 
resolution of the signal. 
Acute oedema defined as 
these T2 areas correlated 
with low voltage areas 
(defined as <0.05mV) and 
was much larger than 
areas covered by DE on 
acute CMR scans. DE was 
present on both acute  
(representing a 
combination of tissue 
oedema, other reversible 
changes and areas that 
will scar completely) and 








Dark Regions of 










37 AF patients 
imaged at three 
time points – pre, 
immediately post 
and at 3 months 
post procedure 
3-T Verio MR 
scanner(Siemens 
Medical Systems) ; 
0.1mmol/kg 
Multihance; 
29/37(78.4%) were AF 
free at 12 months 
DE CMR findings 
immediately post 
ablation(IPA) can be 
categorized as regions of 
hyperenhancement(HE- 
representing a spectrum 
of injuries from 
inflammation to necrosis) 
and nonenhancement(NE 
–representing areas of 
no-reflow); the latter 
being a better early 








al , 2011 







Imaging and the 
Risk of Stroke in 
Patients With 
Atrial Fibrillation 




Either 1.5-T Avanto or 3-
T Verio  MR scanner  
(Siemens Medical 
Solutions);0.1mmol/kg 
Multihance ; 36/387 
(9.4%) patients incurred 
a stroke (time from to 
DE CMR 
22.7±8.8months) 
Significantly higher levels 
of LA fibrosis was 
quantified on  DE CMR 
scans in patients who 
suffered an ischaemic 
stroke. The amount of 
enhancement 
representing extent of LA 
structural remodeling 
could be a valuable 
clinical tool to be used in 
conjunction with the 
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CHADS2 index as a 
marker for both stroke 





ONeill, Gill et 
al ,2012 
Acute Pulmonary 
Vein Isolation is 











25 PAF patients 
imaged at three 
time points – pre, 
immediately post 
and at 3 months 
post procedure 
1.5-T Achieva MR 
scanner (Philips 
Healthcare Best, the 
Netherlands); 
0.2mmol/kg Magnevist; 
14/25 (56%) were AF 
free at 6.5±2.8 months. 
Acute pulmonary vein 
isolation is achieved by a 
combination of reversible 
and irreversible 
circumferential tissue 
injury at the PV-LA 
junction.  A greater 
decline observed from 
acute to chronic DE in 
patients with recurrences 
in comparison to no 
recurrences. This 
suggests the presence of 
more reversible tissue 
injury, providing a 
potential mechanism for 
PV reconnection resulting 
in arrhythmia recurrence. 
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7 Assessment of an Automatic Segmentation Tool for Left Atrial 
Delayed-Enhancement CMR analysis following Radiofrequency 
Catheter Ablation 
7.1 Introduction 
Gaining insights into the understanding of the mechanisms resulting in PV reconnection 
following catheter ablation and improving present AF ablation strategies is important. 
Magnetic resonance imaging (MRI) has been shown to be an effective tool in assessing tissue 
injury following energy application. In particular, delayed enhancement (DE) CMRI has the 
potential to detect changes that take place in the LA when performed pre and post catheter 
ablation. DE-MRI has been extensively used to detect myocardial scarring in the ventricles 
following ischaemic injury 
142
. This technique has recently been extended to be used in 
patients with AF to detect the degree of LA fibrosis prior to ablation
90
; to detect acute 
(<24hrs) post-ablation LA tissue injury 
115
; and to detect chronic (>3 months) postablation 
LA fibrotic scarring caused by tissue injury
112, 118
. 
See Fig. 7.1 for examples of chronic DE-MRI imaging. 
 
Figure ‎7-1: DE-MRI images from three patients taken 3 months post-ablation. Arrows indicate areas of 
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Quantification and segmentation of ventricular scar from DEMRI images is not un-common. 
For ventricular scar, classifying scar into its core and periphery (i.e. grey-zone) has important 
applications. Several studies 
143-145
have employed the fullwidth- half-maximum (FWHM) 
approach, for segmenting the core of the infarct. The FWHM is a straightforward method for 
determining a threshold for the core infarct. It defines core as 50% of the maximum signal 
intensity within a user selected region-of-interest (ROI), which is usually within a hyper-
enhanced scar in the image. The next step is normally thresholding, but some works have also 
employed region growing with thresholding
144
. Patients requiring LA imaging often have an 
irregular heart rate rendering precise cardiac-gated image acquisition a challenge. As a result, 
the image quality in LA DE-MRI can sometimes be sub-optimal. This, alongside the 
relatively thin walled left atrial, makes LA DE-MRI segmentation more of a challenge 
compared to ventricular DE segmentation and analysis. 
Quantification of LA enhancement in DE-MRI has been proposed using thresholding 
techniques for either endocardial surface-based segmentation
115
 or volumetric segmentation
90, 
112, 146
 . In  the former method
115
, the maximum intensity projection (MIP) of the DE-MRI 
signal intensity on the segmented LA shell is first computed for visualizing post-ablation  
injury. The MIP is then thresholded based on a user-selected ROI inside healthy myocardium 
to give a binary segmentation for injury. The selection of the threshold is based on the 
number of standard deviations healthy myocardium is from injury, usually ranging from 3 to 
8. This technique has two important drawbacks: 1) it does not provide a volumetric 
segmentation of injury, and 2) it relies on the correct selection of the threshold which in-turn 
is often dependent on the ROI selected by the user. In the volumetric method 
90
, the authors 
describe a technique for the volumetric segmentation of pre-ablation LA fibrosis. Here the 
LA wall is first manually segmented from the DE-MRI image. Next, the intensity histogram 
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of the segmented DE-MRI wall is analysed by assuming it to be bi-modal and the two means 
are obtained. 
Finally, fibrosis is thresholded as 2-4 standard deviations from the lower mean of the 
histogram. This technique requires a laborious manual task of delineating the LA wall from 
DE-MRI images. Moreover, the LA wall is not always clearly visible in these images, 
especially the epicardial boundary. A similar patient-specific thresholding technique for 
measuring post-ablation chronic scar was also proposed previously 
146
, where the threshold 
level was chosen on visual inspection of an experienced user. The average threshold was 3 to 
6 standard deviations above the blood signal. In
93
the threshold level was chosen as the 
minimum threshold which eliminates most blood pool pixels. However, thresholding in this 
manner can fail to exclude normal myocardium with intensity levels above that of blood pool. 
All the existing techniques described above are essentially thresholding techniques that can 
have major limitations. They suffer from poor reproducibility of segmentations especially 
when the correct threshold level is not selected and often requiring the level to be set by an 
expert user. They also fail to preserve the continuity of shape in structures. With a certain 
level of noise expected in MR images, thresholding often generates holes in structures that it 
segments. Also, employing a global threshold for the entire image leads to segment 
disconnected islands of segmented regions that are not likely to be related to fibrosis/tissue 
injury/scar. 
This study examines a novel segmentation method for LA DE-MRI. It is based on a 
probabilistic tissue intensity model of DE-MRI data, which is derived both from training and  
data. The algorithm uses a Markov random field (MRF)-based energy formulation that is 
solved using graph-cuts
147
. The method of graph-cuts has shown high accuracy, simultaneous 
ROI detection, and scalability to three dimensions in segmenting structures 
148
. It has been 
applied in a wide variety of segmentation problems arising in computer vision and medical 
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image processing 
149, 150
. We use it to efficiently solve our MRF model. The automatic 
method was previously validated using digital phantoms by our department in Kings’s 
College London This further preliminary work has been performed on 11 patients who 
underwent ablation treatment for AF and were imaged at approximately 6 months post-
procedure. The segmentations are compared to expert manual segmentations and existing 
semi-automatic approaches 
90, 115
. This study focuses on segmentation of post-ablation 
chronic scar from DE-MRI but the algorithm could equally be applied to pre-ablation fibrosis 
or post-ablation acute tissue injury if different training data were used. 
7.2  Clinical and Imaging Protocols 
7.2.1 Patients 
11 patients were followed up at 6 months following their first ablation for the treatment of 
paroxysmal AF. The procedures were carried out in the cardiac catheterization laboratory at 
St. Thomas Hospital, London, U.K. All patients gave written permission to take part in this 
local ethics committee approved study. 
7.2.2  Ablation procedure 
This section has been described more elaborately in Chapter 4. In summary, two trans-septal 
punctures were made to access the left atrium using standard long sheaths (St. Jude Medical, 
MN, USA). A three-dimensional (3D) LA geometry was created using either EnsiteNavX (St. 
Jude Medical, MN, USA) or CARTO XP (Biosense Webster, Diamond Bar, CA, USA). A 
circular mapping catheter was then placed in each PV in turn while the corresponding LA-PV 
ostium was targeted with wide area circumferential ablation. Energy was delivered through a 
3.5 mm irrigated tip catheter with flow limited to 17 ml/min, power limited to 30 W on the 
anterior wall and 20 W on the posterior wall and temperature limited to 50 _C. Ablation 
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lesions were marked on the LA geometry when there had been an 80% reduction in the local 
electrogram voltage or after 30seconds of energy delivery. 
7.2.3 Postablation MRI procedure 
The CMR protocol used has been described previously in Chapter 4. The scan sequence 
utilised for the visualization of delayed-enhancement was a 3D ECG-triggered, free breathing 
inversion recovery (IR) turbo field echo (TFE) with respiratory-navigated and cardiac-gated 
with whole heart coverage. The pixel resolution was reconstructed to 1.3x1:3x 2mm
3
. Please 
refer to Chapter 4 section 3 for a full description of the CMR imaging technique utilised. 
7.2.4   Computational Analysis  
A summary of the steps involved in the proposed segmentation technique utilised by the 
automatic.software is presented in Fig. 7.2 Starting with the training images of manually-
segmented scars, the intensity energy model for scar is trained on the scar-to-blood-pool 
ratios of voxels labelled as scar. The neighbourhood model is also obtained from the training 
images, where a value for the scale _ in the Lorentzian norm is derived by sampling intensity 
gradients within tissues surrounding scar. 
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Figure ‎7-2: An overview of the steps involved in the graph-cut segmentation. 
 
The intensity energy model for non-scar is obtained from the target image by locating regions 
of blood-pool, atrial wall and pericardium. This is accomplished by fitting a multi-modal 
Gaussian with the EM-algorithm. The above intensity models allow a graph to be constructed 
where each voxel of the target image denotes a node in the graph. The edge weights for each 
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node are derived from the intensity models, based on its intensity. The minimum s-t cut is 
computed resulting in the optimal segmentation of the target image into foreground (i.e.scar) 
and background. Following segmentation, the intensity model for scar is updated based on 
the obtained segmentation. 
If  the new model is sufficiently close to the old model in terms of its mean and variance, the 
segmentation process is terminated; otherwise the entire process (starting with graph 
construction) is repeated with this new model for scar. This feedback strategy is important as 
it allows to obtain the optimal scar model for the target image, which is often not the model 
obtained from the training. Nevertheless, the training model provides with a good initial 
starting estimate. 
7.2.5 Clinical data 
Here, segmentations from the proposed algorithm and the manual segmentations of three 
observers were compared. For manual segmentations, the observers were blinded to the 
results from the automatic and semi-automatic segmentations. Regions of scar were located 
and marked using ITK Snap in the manual segmentations. All experiments were run on a 2.8 
GHz PC. 
In a separate set of experiments, we obtained volumetric segmentation of scars from 3 
observers. These observers had prior experience looking at scars in DE-MRI. The observers 
were blinded to the results from the automatic and semiautomatic segmentations. Each 
observer was provided with DE-MRI scans from the 11 patients. Scars in the images were 
segmented slice-by-slice using ITK-Snap (www.itk-snap.org) using a simple digital paint-
brush tool with a variable tip width. Each patient took approximately 15-45 minutes 
depending on the amount of scar in the image. The agreement between observers was 
analyzed by comparing their segmentations using the Dice overlap measure. 
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It is also important to note that segmentations from the proposed approach were obtained 
automatically without any user interaction necessary at any step of the algorithm. The total 
time to obtain segmentations from the proposed approach was less than a minute on a 2.5 
GHz PC. For semi-automatic segmentations, the expert observer was required to carefully 
select the correct threshold levels, often requiring an additional 2-3 minutes depending on the 
user’s level of experience. 
7.3 Results 
Segmentations from the algorithm on clinical datasets can be seen in Fig. 7.3. Both the raw 
MR data and the corresponding segmented scar area is presented in this figure. These 
findings were then presented as maximum intensity projection (MIPs) onto the corresponding 
3-D atrial surface shells. Manually segmented areas of scar was presented in the similar way, 
 A good correspondence was found between the segmentations.. Fig.7.4 shows some of these 
visualizations confirming the good correspondence. 
Results comparing manual segmentations of three different observers are given in Table 7.1. 
A relatively low degree of agreement was found, especially with the third observer (mean 
Dice = 0:2; 0:3). All observers found the task of manually segmenting scars difficult, time 
consuming and laborious. In many patients, scars were not as distinctly visible as others, 
owing to the poor signal-to-noise and scar-to blood- pool ratios. Also, sometimes scars 
appeared as thin lined structures in the image and as a result made the labelling task 
increasingly difficult. In most cases where observers labelled thin lined scar regions, the 
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Figure ‎7-4 : Probabilistic map of scar for three patients shown alongside their manual segmentations from an observer. The probabilistic map is obtained by 
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Table ‎7-1 The degree of agreement between observers. 
 
Moreover, an observer is often reluctant to repeatedly change the width of the tip of the brush 
to adapt to the size of the scar. This exaggerated the extent of scar in some regions and 
explains to some extent the inter-observer variability in the segmentations. 
7.4 Discussion 
The results presented in this work demonstrate that the fully automatic technique is well 
suited for segmenting scars in the LA from DE-MRI images. With good overlap with three 
expert manual segmentations and two established semiautomatic techniques, the proposed 
technique was able to segment scars with good accuracy. Because of the absence of ground 
truth for scar in real patient DE-MRI datasets, it becomes difficult to evaluate segmentations 
of scar from the algorithm. The next best approach is to compare it to manual segmentations 
and we have demonstrated that there is a high degree of inter-observer variability, primarily 
due to low image quality often encountered in LA DE-MRI scans. 
It was shown that the proposed approach is suitable for extracting scar from post-ablation 
clinical MRI data. It overcomes many of the limitations of existing semi-automatic 
approaches. A major limitation is the high inter-observer variability, especially in the 
threshold selection stage, making it difficult to reproduce the segmentations. Also as it is 
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technically challenging to achieve good nulling of the myocardium and blood-pool, the 
intensity ranges for non-scar tissues are bound to overlap with scar. Since all existing 
approaches essentially rely on thresholding, a single intensity cut-off for scar is insufficient. 
The proposed method overcomes this by considering not only a voxel’s intensity alone but 
also its intensity in relation to its neighbours and its intensity in relation to the training data. It 
then computes a global optimal solution using a well established optimization technique. 
A second major advantage over existing approaches is that it is fast and fully automatic 
requiring no expert user interaction. On a 2.8 GHz PC, the graph-cuts stage generating the 
scar segmentation takes less than 1 minute.  
The proposed technique has some limitations. The quality of the LA segmentation can affect 
the algorithm’s output. Since the technique utilizes the LA segmentation as a base-line to 
identify regions of blood pool, myocardium and pericardial regions, a mis-segmentation of 
the LA can cause regions of the myocardium to overlap with other tissues. This is generally 
not an issue as the algorithm is well-equipped to discard tissues that are dissimilar to its 
training data. However, this becomes an issue when the aortic wall, which is almost always 
hyper-enhanced in DE-MRI images, overlaps with the myocardium and is segmented as scar. 
This can be overcome if a segmentation of the aortic wall is also available.  
A second limitation that can cause the algorithm to sometimes oversegment is a diffused 
high-signal intensity artefact almost always present in the right superior PV. This is caused 
due to the respiratory navigator used during scans. The algorithm is not yet equipped to 
ignore this artefact. However, incorporating spatial information about each vein and 
exclusively training it on the intensity levels of the artefact will make it possible to avoid 
segmenting these regions. More importantly, the work from chapter 6 utilising a novel dual 
inversion recovery sequence assists in improving image acquisition quality with good blood 
pool suppressions and less artefactual signal intensities .This has a role in facilitating the use 
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of this software As both projects were running in parallel, we intend to evaluate the scar 
segmentation utilising this software on the images acquired using the new sequence. 
7.5 Conclusion 
The use of DE-MRI for imaging RF ablation lesions has allowed a more in depth 
characterization of lesions. This study presents an automatic segmentation approach for 
segmenting lesions from DE-MRI. It is envisaged that user-independent lesion segmentation 
with low computational cost will allow for standardization of DE-MRI as a marker for  
cardiac injury. Future work will focus on improved training and validation using a larger 
patient cohort with more expert segmentations per data set. It will also be interesting to adapt 






8.1 Characterisation of post ablation lesions and an assessment of the 
temporal relationship between DE and T2 signal 
8.1.1 CMR left atrial tissue injury assessment : Reversible and irreversible tissue injury 
Serial CMR scans performed  immediately following catheter ablation ( within 18 to 24 hours 
post procedure, acute scans) and at 3-5 months post procedure (late scans) has enabled CMR 
evaluation of the nature of left atrial tissue injury. Based on the two observations made- that 
firstly areas of DE regressed to varying levels in all patients on the late scans whilst T2 signal 
reduced to near baseline pre procedural levels and secondly the association between greater 
acute T2 signal and a higher DE regression on the chronic scans suggest the presence of  
reversible and irreversible acute tissue injury. This is likely to reflect ablated but not 
necessarily necrotic tissue confirming previous work, including that from our own laboratory, 
that acute DE MRI overestimates the acute extent of tissue injury following left atrial catheter 
intervention by virtue of the accumulation of gadolinium in extravascular water associated 
with acute inflammation. Although there is a good correlation between endocardial voltage-
defined scar and T2 weighted signal immediately post ablation, there is a poor correlation 
with the DE MRI-defined scar at three months follow up 
124
, further supporting the transient 
nature of at least part of the ablation injury process. 
8.1.2 Atrial scar and arrhythmia recurrence 
The  significance of both acute and late CMR scan findings were evaluated by correlating the 
DE and T2 encirclement to clinical outcome. We observed that a greater extent of 
circumferential DE signal at the 24h scan was predictive of freedom from AF  while the 




with greater initial DE and a lower acute T2 had a lower subsequent DE regression which 
correlated well with being arrhythmia free.  The clinical significance of this has been further 
elaborated in the discussion section of Chapter 4. 
8.2 CMR comparison of lesions created using robotic navigated systems 
against lesions created in the conventional way 
8.2.1 PV encirclement by DE: more versus less 
This work reports the first cardiac MR findings comparing robotic navigated catheter ablation 
lesions to standard catheter ablation. The higher mean percentage encirclement consistently 
observed in the robotic group in both acute and late scans is likely to be a function of both 
catheter stability and tactile feedback with Intellisense conferring better catheter control. 
Improved lesion delivery resulting in an overall 10% higher margin encirclement was 
observed on the robotic navigated late scans. Whilst almost similar % encirclements were 
observed on late scan DE between the two groups with no recurrences, a significantly higher 
amount of DE was noted in the robotic group. This lower regression of DE between the acute 
and late scans in the robotic recurrences group suggests an overall better quality lesion 
created using the Robotic Navigation System (RNS).  The clinical significance and a 
comparison of contemporary robotic assisted procedures against standard catheter ablation 
has been commented upon in the discussion section of chapter 5.   
8.2.2 Lesion set appearance: more versus less contiguous 
The overall more contiguous lesion set appearance on qualitative examination of the 3-D 
CMR atrial shells in the robotic group is again attributable to better catheter control and 
greater stability.  More circular shaped encirclement patterns observed in the RNS group 
suggests that the system allows for a more accurate and precise catheter movement along the 




8.3 DE imaging sequence optimization: A comparison between non-
selective dual inversion recovery (NSDIR) versus standard selective 
single inversion recovery (SSIR) 
8.3.1 CNR and SNR Image analysis 
The need for better image acquisition is important to enable better visualization of scar 
boundary  which in return allows for better localization of areas of tissue injury and a more 
accurate quantification of scar burden. The novel scan sequence acquisition using non-
selective dual inversion recovery imaging has shown to achieve superior blood suppression at 
an earlier time point. There is effective atrial blood pool nulling that is achieved within 15 
minutes with this NSDIR sequence in comparison to 25-30 minutes with the conventional 
sequence.  A more than adequate atrial blood pool nulling was achieved without the 
compromise of scar visualization.  This scanning sequence enables an overall improvement in 
image quality with the added bonus of a shorter acquisition time. The latter is important in 
improving patient journey and experience within the MR scanner and optimising resources by 
reducing scan duration time whilst the former ensures quality control. The potential clinical 
significance of this is elaborated in the discussion section of Chapter 6. 
8.4 Novel automatic delayed enhancement lesion segmentation tool 
8.4.1 Motivation behind developing an automatic tool 
Delayed enhancement assessment by CMR has several potentials within the research and 
clinical domain. In the former, its role as a biophysical marker in studies can proof to be a 
useful surrogate. Quantifying total areas and distribution of these areas following energy 
delivery is useful in the development of and assessment of newer ablation technology – 




(force sensing catheters , gold tip catheters). In the clinical domain, a potential role of DE 
CMR imaging maybe in the guidance and planning of re-do ablation procedures.   
In order to achieve the above, a robust reproducible system is required in segmenting out 
areas of delayed enhancement. With respect to this, we examined a novel systems platform 
that automatically segments out areas of DE from the raw scan data.  
8.4.2 Advantages conferred by the automatic segmentation technique 
A comparison between segmentations performed manually by hand by three experienced 
CMR readers against DE segmentations performed by the automatic alogorithm.  Zones of 
enhancement were relatively similar between the two groups. Importantly, this suggests that 
the tool was able to correctly identify regions of DE and perform the segmentation at much 
quicker rate. Furthermore, a standardised technique would negate the inter-observer 
variability, thus increasing reproducibility, accuracy and precision. 
As mentioned above, this tool overcomes a major limitation in the existing semi-automatic 
technique by minimising inter-observer variability, especially in the thresholding selection 
stage. Moreover in some instances, it is technically challenging to achieve good nulling of the 
myocardium and blood-pool,with intensity ranges for non-scar tissue areas overlapoing with 
areas deemed as scar. Since all current existing approaches rely on thresholding, a single 
intensity cut-off for scar is insufficient. Here, the proposed method overcomes this by 
considering not only a voxel’s intensity alone but also its intensity in relation to its 
neighbours and its intensity in relation to the training data. It then computes a global optimal 
solution using a well established optimization technique. 
A second major advantage over existing approaches is that it is fast and fully automatic 
requiring no expert user interaction. On a 2.8 GHz PC, the graph-cuts stage generating the 
scar segmentation takes less than 1 minute. The volumetric segmentations generated allow 




This is advantageous as scar visualizations on LA shells can be used for assessing lesion 
gaps. Also, volumetric segmentations are vital for computing scar thickness especially for the 
assessment of transmurality which is becoming an important domain in understanding 
mechanisms of PV reconnection in AF recurrence.  
8.5 Future Work: Novel Hybrid Imaging Platform for Real-Time Image 
Guidance in Catheter Ablation 
 CMR has a role in assessing post ablation tissue injury for both research in ablation 
technology development and in clinical use by providing a road map of  in vivo lesions 
created within the atrium. The potential role in providing real time image guidance is 
currently being developed.  Mapping and ablating catheters compatible within the magnetic 
scanner are undergoing phase 1 studies alongside electro-anatomic mapping systems and 
other equipment being designed to function within the magnetic field environment. One 
important consideration is the materials used for the measurement of intra-cardiac potentials 
such that electrical information is not affected by the magnetic field and simultaneously, the 
electrical flow does not create image artefacts within the scanner. 
Translating CMR into a real-time image guidance tool for catheter ablation within patients 
may take some time to be perfected. However, the combination of fluoroscopy and 
echocardiography imaging modalities to provide real time catheter – tissue information is 
within reach and does not require a high capital investment to be set up. With this in mind we 
assessed a novel platform that integrates the echo matrix into the fluoroscopy matrix. 
8.5.1 Novel System for Real-Time Integration of 3D Echo and Fluoroscopy for Image 
Guidance: Systems Overview 
The scanning setup comprises a Philips AlluraXper FD10 C-arm X-ray system and a Philips 




each system to a PC running the visualisation software. The software displays a 2D 
projection view in the coordinates of the X-ray image, overlaid with a projection of the echo 
volume. Figure 8.1 illustrates an example of an X-ray view and an echo volume integrated to 
obtain the hybrid view. 
 
Figure ‎8-1: Both the X-ray fluoroscopic image and echocardiogram image are acquired separately and 
streamed into the visualisation platform that allows for the real-time integration of the two matrices 
 
The two views are registered using the projection image of the TEE probe in the X-ray using our 
previously described method
10
. In brief, the registration is initialised manually to approximately the 
correct position and orientation before running an automatic 3D-2D registration algorithm. Following 
the manual registration,2 different X-ray views (ie AP and LAO 30 or RAO 30) are acquired and the 




respiratory motion. The automatic GPU (Graphic Processing Unit, NVIDIA GeForce 8800GTX)- 
accelerated registration updates in this way at a rate of 1–2Hz. Figure 8.2 shows a typical X-ray view, 
the probe model and a registration of the two. The study was divided into 2 phases. The preclinical 
phase involved data acquisition during a porcine experimental study. The clinical phase, involved data 
acquisition following software application during  AF ablation (9 patients) and TAVI (2 patients) 
following approval from the Local Research Ethics Committee. The preliminary results of the use of 
this prototype software is shown in the following figures 8.2 to 8.4.. 
 
Figure ‎8-2: (a-c) Phantom model experimental overlay of fluoroscopic and echocardiographic images. 
Errors were measured between automatically defined landmarks on straight line models of the crossed 
wires. (d-f) Porcine experimental study overlay. Errors are measured as the shortest distance from 






Figure ‎8-3: Clinical study to document feasibility in an AF ablation case. Real-time hybrid views were 
generated during the trans-septal puncture and subsequent placement of circular mapping and ablation 
catheters within the left atrial chamber. 
 
 
Figure ‎8-4: Clinical study to document feasibility in a TAVI case. Real-time hybrid views were generated 
during the placement of the Edwards core valve within the native aortic valve followed by the deployment 





8.5.2 Real-time hybrid X-ray fluoroscopy and 3D echo visualisation in patients 
Successful real-time integration was achieved in all 11 clinical cases. Figures 8.3 and 8.4 show typical 
examples of overlays from the catheter ablation and TAVI cases.. One of the potential advantages of 
the hybrid echo-fluoro imaging modality is increased and more precise control of the catheter/ guide-
wire. Visualization of catheter direction in relation to the anatomical structures facilitates faster and 
more accurate catheter movement to the intended anatomical site. 
 An echo volume on its own can be difficult to interpret because of its limited field of view and lack 
of context for the echo coordinate system relative to the patient. Catheters and devices tend to produce 
artefacts in the ultrasound data reducing the clarity of the images. In the overlay view, the echo 
volume is displayed in a coordinate system that can be more easily related to the patient. Also, the 
highly visible catheters in the X-ray image help with identifying the catheters in the echo and so can 
be related to the cardiac anatomy via the echo image.   During an ablation procedure, the precise 
location of the catheter tip and electrodes on the mapping catheter in relation to atrial tissue permits 
better targeted lesion delivery than just visualizing the catheter as a whole on fluoroscopy. Similarly 
during a TAVI procedure, being able to visualize both the native valve and the prosthesis on a single 
image will facilitate delivery and deployment of the prosthetic valve. 
The accuracy requirement for a clinically useful image guidance system depends on many factors 
including the patient and the type of procedure being performed
151, 152
.  
Ultimately, randomized comparisons of real-time hybrid X-ray fluoroscopy and 3D echo image-
guided therapy with standard visualization approaches are necessary to definitively establish its 
clinical utility and translate it from an experimental method to a clinical routine. 
8.5.3  Present Limitations 
It is important to recognize that one of the main objectives of this prelimary study was to assess the 
clinical feasibility of the proposed method. Although all the porcine experimental and clinical data 
were acquired specifically for this study, the data analysis was performed off-line. Our future work 




In addition our approach of measuring to the closest point accounts for 2-D in plane errors  does not 
necessarily capture the complete error as there can also be misalignment tangentially to the catheters. 
The clinical case numbers in this study at present time is small. Further studies involving larger 
patient groups are required to demonstrate that this novel technique translates into reduced 
fluoroscopy time, reduced complications and better overall patient outcome. 
In this study, the practicability of real-time hybrid X-ray fluoroscopy and 3D echo visualisation was 
demonstrated in both a phantom model and a porcine experimental study, followed by a clinical series 
demonstrating work-flow feasibility. Further clinical validation and a randomized comparison 
between real-time hybrid echo-fluoro image-guided therapy versus standard visualization approach is 
needed to translate this tool into routine clinical practice. 
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9 Conclusion 
Cardiac Magnetic Resonance Imaging in Atrial Fibrillation has a number of  significant roles. 
The examination of tissue injury on cardiac CMR allows for the characterisation of lesions 
created following energy delivery. Serial delayed enhancement and T2 signal quantification 
around the PV antrum performed following catheter ablation demonstrated both a range of 
percentage encirclement and heterogeneity in the ratios of DE and T2 combination 
contributing towards the encirclement. Whilst on the acute scans both DE and T2 were 
observed, DE remained the predominant signal on the late scans. T2 generally resolved to 
near baseline levels.  A comparison between acute and late scans demonstrated that DE 
resolved to varying degrees. Importantly DE associated with higher T2 signal on the acute 
scans had greater amount of signal regression and hence lesser amount of PV percentage 
encirclement. The clinical significance of this became apparent following the correlation of 
CMR findings to procedural outcome was assessed. Arrhythmia free patients had lower 
amount of initial T2 signal with higher amounts of DE quantified on both acute and late 
scans. Conversely, patients with recurrences had greater amounts of T2 and a larger 
regression in DE encirclement. The latter CMR findings allows for the potential 
categorisation of  acute in vivo lesions into reversible and irreversible tissue injury. The 
continued trend of patients with higher DE and lower T2 signal on the acute scans having  no 
AF recurrences at 6 months follow up suggests that CMR left atrial imaging has a role as an 
adjunct tool in clinical work to further understand recurrences of AF following catheter 
ablation. 
The cardiac MR comparison between robotic assisted and standard catheter ablation suggest 
that remote robotic assisted navigation systems permit the creation of more contiguous, 
durable scar around the PV antrum.  These CMR findings are the first to examine, report and 
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correlate in vivo lesion patterns created by robotic assisted catheter ablation to clinical 
outcome.  On the whole, greater amounts of delayed enhancement was observed in the 
robotic group with an overall 75% success rate following 1.2 procedures in comparison to a 
60% success following 1.40 procedures in the standard group. The recurrence arrhythmia 
pattern of atrial tachycardia which was greater in numbers in the RNS group suggests that the 
index ablation had successfully modified the arrhythmia into a more organised rhythm which 
was successfully ablated during the subsequent procedure.  
Left atrial CMR delayed enhancement important an assessing the extent of post ablation 
tissue injury. A pilot study within this research has established that non-specific dual 
inversion recovery achieves better atrial blood pool suppression conferring improved delayed 
enhancement visualisation whilst reducing patient time within the scanner. The correlation 
between clinical outcome and improved visualisation enabling more accurate and precise scar 
quantification needs to be assessed in a larger clinical series. 
The precision of left atrial scar quantification performed is important and requires a technique 
conferring high reproducibility. The comparison of a novel automatic segmentation tool to 
hand hand segmented lesions from DE-CMR images demonstrated a good correlation. This 
suggests that the tool is able to automatically identify the required pixels and segment out 
areas of atrial scar.  Operator-independent lesion segmentation allows for greater 
reproducibility achieved over shorter time periods in addition to time and cost optimisation. 
Further work on improving software training and validation using a larger patient cohort is 
currently in progress.  
In light of the above findings, CMR left atrial lesion imaging has a potential role as a 
surrogate biophysical marker in assessing newer catheter ablation technology to improve 
160 
 
Cahpter Nine- Conclusion 
lesion delivery. Catheter stability, good tissue contact force and adequate force time integral 
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confidence intervals (yellow box) and 1 standard deviation  (blue box) An overall higher 
enhancement is seen in all 6 groups on the acute scans compared to the 6 groups on the chronic 
scans.  The % encirclement by T2 signal diminishes from above 75% to about 5% in keeping with 
reversible injury. The % encirclement by DE signal diminishes to a much lesser extent. Using a 
combination of DE and T2 signal,  the % encirclement decreases from 90% at the acute scans to 
approximately 50% at the follow up scan ............................................................................................. 83 
Figure ‎4-6 :.This scatter-boxplot shows a comparison of percentage of PV encirclement according to 
clinical outcome no recurrence (NR) v recurrence (R) of AF  accounted for by T2 signal, DE signal and 
combined T2&DE at three time points: pre-ablation (Pre) immediately post (Acute) and follow up 
scans (Late). Each individual scatter plot represents the raw data for that specific group. The dots 
within each group have been dispersed horizontally to optimise visualisation and clarity. The 
boxplots on the other hand represent median(red line), 95% confidence intervals (yellow box) and 1 
standard deviation  (blue box).  The absolute decline in DE is less for patients with no AF recurrence.
 .............................................................................................................................................................. 84 
Figure ‎4-7: Mean DE/T2&DE ratios quantified on the acute scans for patients with no recurrences 
versus those with recurrences. An overall higher DE/T2&DE ratio is seen in patients free from AF. .. 85 
Figure ‎5-1: The above flow diagram describes this single centre study  performed over 18 months. Of 
the 45 patients consented, 3 developed claustrophobia during CMR image acquisition and 2 had 
suboptimal images due to navigator inefficiency. The remaining 40 patient studied underwent the 
same catheter ablation strategy for paroxysmal atrial fibrillation and were imaged between 3-4 
months post procedure. Both selected single inversion recovery, SSIR and non-selective dual 
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